{\rtf1 \ansi 
{\colortbl;
\red0\green0\blue0;
\red255\green255\blue255;
\red255\green0\blue0;
\red0\green255\blue0;
\red0\green0\blue255;
\red0\green255\blue255;
\red255\green0\blue255;
\red255\green255\blue0;
\red0\green0\blue128;
\red0\green128\blue128;
\red0\green128\blue0;
\red128\green0\blue128;
\red128\green0\blue0;
\red128\green128\blue0;
\red128\green128\blue128;
\red192\green192\blue192;
\red170\green170\blue170;
\red85\green85\blue85;
\red107\green107\blue106;
\red14\green86\blue140;
\red33\green33\blue33;
\red37\green37\blue37;
\red255\green255\blue102;
\red119\green119\blue119;
\red238\green238\blue238;
\red20\green93\blue164;
\red246\green246\blue246;
\red204\green204\blue204;
\red80\green80\blue80;
\red51\green51\blue51;
\red112\green112\blue112;
\red187\green187\blue187;
\red181\green79\blue104;
\red151\green151\blue151;
\red21\green137\blue21;
\red86\green86\blue86;
\red61\green61\blue61;
\red218\green218\blue218;
\red227\green232\blue250;
\red70\green70\blue68;
\red250\green250\blue250;
\red240\green240\blue240;
\red70\green70\blue70;
\red250\green222\blue100;
\red61\green61\blue60;
\red255\green204\blue153;
\red254\green254\blue0;
\red106\green144\blue39;
\red255\green248\blue96;
\red214\green214\blue214;
\red56\green124\blue43;
\red247\green247\blue247;
\red0\green114\blue54;
\red232\green233\blue232;
\red249\green249\blue249;
\red203\green203\blue203;
\red127\green127\blue127;
\red71\green120\blue194;
\red245\green245\blue245;
\red214\green9\blue9;
\red188\green41\blue30;
\red190\green237\blue228;
\red105\green105\blue105;
\red227\green227\blue227;
\red190\green190\blue252;
\red233\green233\blue233;
\red236\green236\blue236;
\red118\green118\blue118;
\red153\green153\blue153;
\red240\green248\blue255;
\red229\green243\blue255;
\red179\green218\blue255;
\red255\green255\blue204;
\red255\green204\blue0;
\red255\green255\blue174;
\red223\green223\blue223;
\red239\green239\blue239;
\red255\green255\blue198;
\red120\green162\blue47;
\red251\green252\blue255;
\red72\green72\blue72;
\red190\green195\blue204;
\red208\green208\blue208;
\red228\green231\blue232;
\red102\green0\blue102;
\red255\green210\blue183;
\red183\green242\blue206;
\red239\green122\blue2;
\red249\green250\blue251;
\red107\green107\blue107;
\red221\green195\blue236;
\red182\green231\blue243;
\red255\green194\blue211;
\red172\green172\blue172;
\red9\green56\blue84;
\red204\green255\blue255;
}
{\fonttbl {
\f0 Arial;}{
\f1 Symbol;}{
\f2 Times New Roman;}{
\f3 georgia;}{
\f4 sans-serif;}{
\f5 Source Sans Pro;}{
\f6 serif;}{
\f7 Courier New;}
}
{\*\generator Apache XML Graphics RTF Library;}
\fet0 \ftnbj \paperw12240 \paperh15840 \margt1080 \margb1080 \margl1080 \margr1080 \headery720 \footery720 \itap0 \cols2 
\sectd {\header {
{\trowd \ltrrow \trleft0 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrl \trql \clvertalb \clwWidth9380 \cellx9380 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrr \trql \clwWidth700 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
{\b1 \cf18 \f0 \i0 \fs18 
{\b1 \cf18 \f0 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Kaneka Corp. v. Zhejiang Medicine Co., Ltd., Not Reported in Fed. Supp. (2018)
}
}
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
}\b0 \cf1 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs18 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 
}\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
}\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 \intbl \cell \row }}\par }{\footer {
{\trowd \lastrow \trleft0 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrl \trql \clvertalb \clwWidth9300 \cellx9300 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrr \trql \clwWidth700 \cellx10000 
\intbl 
{\b0 \cf17 \f0 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 
}
{\*\shppict {\pict \pngblip \picw78 \pich10 \picwgoal1170 \pichgoal150 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}}
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
}
}\b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs20 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf17 \f0 \ri0 \i0 \fs20 \li0 
{\b0 \i0 \ul0 \fs20 \f0 \chpgn }
}\qr \b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \fs20 \li0 \intbl \cell \row }}\par }
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_document_63}{\*\bkmkend co_document_63}
{\b0 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart I59a0a1f06a1f11e8abc79f7928cdeab9_Target}{\*\bkmkend I59a0a1f06a1f11e8abc79f7928cdeab9_Target}
\par 
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb100 
2018 WL 2718036
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Only the Westlaw citation is currently available.
\par 
}
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
United States District Court, C.D. California.
\par 
}
}
}
{\b0 \qc \cf22 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf22 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf22 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf22 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb240 
KANEKA CORP.
\par 
}
}
{\b0 \qc \cf22 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf22 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
v.
\par 
}
}
{\b0 \qc \cf22 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf22 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb0 
ZHEJIANG MEDICINE CO., LTD. et al.
\par 
}
}
}
}
{\b0 \qc \cf1 \f2 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Case No.: CV 11\u8211\'3f02389 SJO (SHSx)
\par 
}
}
}
{\b0 \cf1 \f3 \i0 \fs20 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
|
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
Filed 04/05/2018
\par 
}
}
}
}
{\b1 \cf21 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_attorneysAndLawFirms_63}{\*\bkmkend co_attorneysAndLawFirms_63}
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Attorneys and Law Firms
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Donald Atkinson, El Dorado Hills, CA, pro se.
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0166539101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Nancy Joan Sheehan
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0447443601&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Beatriz Berumen
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, Porter Scott, PC, Sacramento, CA, for Zhejiang Medicine Co., Ltd. et al.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf21 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_opinion_63}{\*\bkmkend co_opinion_63}
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia15124e2053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia15124e2053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia171cc41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia171cc41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
PROCEEDINGS (in chambers): ORDER (1) GRANTING IN PART AND DENYING IN PART PLAINTIFF\rquote S MOTION FOR PARTIAL SUMMARY JUDGMENT ON DEFENDANTS\rquote  CLAIMS OF PATENT INVALIDITY UNDER 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b1 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f\u167\'3f
}
}
{\b1 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b1 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
102
}}}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, & 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
112
}}}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u182\'3f 2
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 [Docket No. 556]
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; (2) GRANTING IN PART AND DENYING IN PART DEFENDANTS\rquote  MOTION FOR SUMMARY JUDGMENT AS TO INVALIDITY AND NONINFRINGEMENT OF
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f2 \i0 \fs20 
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. PATENT NO. 7,910,340
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 [Docket No. 559]
}}}
\sa200 
\sb400 
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; (3) DENYING PLAINTIFF\rquote S MOTION FOR RECONSIDERATION OF THE COURT\rquote S MODIFICATION OF THE FEDERAL CIRCUIT\rquote S INTERPRETATION OF \u8220\'3fSEALED TANK\u8221\'3f
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb600 
 [Docket No. 819]
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0136674401&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
S. JAMES OTERO
}}}
\sa200 
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
, UNITED STATES DISTRICT JUDGE
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_1_63}{\*\bkmkend co_pp_sp_999_1_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 This matter is before the Court on (1) Plaintiff Kaneka Corporation\rquote s (\u8220\'3fKaneka\u8221\'3f or \u8220\'3fPlaintiff\u8221\'3f) Motion for Partial Summary Judgment on Defendants\rquote  Claims of Patent Invalidity Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f\u167\'3f
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, & 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u182\'3f 2 (\u8220\'3fKaneka Motion\u8221\'3f); and (2) Defendants Shenzhou Biology and Technology Co., Ltd. (\u8220\'3fShenzhou\u8221\'3f), Xiamen Kingdomway Group Company (\u8220\'3fXKGC\u8221\'3f), Pacific Rainbow International, Inc. (\u8220\'3fPRI\u8221\'3f), Sojitz Corporation of America (\u8220\'3fSojitz\u8221\'3f), and Rochem International, Inc.\rquote s (\u8220\'3fRochem\u8221\'3f) Motion for Summary Judgment as to Invalidity and Noninfringement of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 7,910,340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fDefendants\rquote  Motion\u8221\'3f), both filed December 19, 2016. Defendants opposed Kaneka\rquote s Motion for Summary Judgment (\u8220\'3fDef.\u8217\'3fs Opposition\u8221\'3f) and Kaneka opposed Defendants\rquote  Motion for Summary Judgment (\u8220\'3fKaneka Opposition\u8221\'3f) on January 9, 2017. The parties filed reply briefs in support of their summary judgment motions (\u8220\'3fKaneka Reply\u8221\'3f and \u8220\'3fDef.\u8217\'3fs Reply,\u8221\'3f respectively) on January 16, 2017. On September 11, 2017, at the invitation of the Court, Plaintiff filed a Supplemental Brief In Opposition to XKGC\rquote s Motion for Summary Judgment (\u8220\'3fPl.\u8217\'3fs Supplemental Brief\u8221\'3f) to which Defendants responded (\u8220\'3fDef.\u8217\'3fs Supplemental Reply\u8221\'3f) on March 9, 2018. Also before the Court is Plaintiff\rquote s Motion for Reconsideration of the Court\rquote s Modification of the Federal Circuit\rquote s Interpretation of \u8220\'3fSealed Tank\u8221\'3f (\u8220\'3fMotion for Reconsideration\u8221\'3f), filed March 5, 2018. Defendants opposed Kaneka\rquote s Motion for Reconsideration (\u8220\'3fDef.\u8217\'3fs Opp\rquote n to Mot. For Reconsideration\u8221\'3f) on March 9, 2018 and Kaneka filed its reply brief (\u8220\'3fPl.\u8217\'3fs Reply ISO Mot. For Reconsideration\u8221\'3f) on March 13, 2018. Since the filing of the parties\u8217\'3f summary judgment motions, Plaintiff has dismissed its claims with respect to all but two Defendants, XKGC and PRI (together, the \u8220\'3fDefendants\u8221\'3f). The Court found these matters suitable for disposition without oral argument and vacated the hearing set for January 30, 2017. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR78&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Fed. R. Civ. P. 78(b)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. For the following reasons, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS IN PART
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES IN PART
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the Kaneka Motion and Defendants\rquote  Motion and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Plaintiff\rquote s Motion for Reconsideration.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia174b271053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia174b271053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia174b271053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia174b271053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
I. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
FACTUAL AND PROCEDURAL BACKGROUND
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia174b271053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia174b271053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
\sb200 
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
This is a patent infringement action involving 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 7,910,340 (the \u8220\'3f \lquote 340 Patent\u8221\'3f)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, titled \u8220\'3fProcesses for Producing Coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f Coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fCoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f) exists in animal cells, which use CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to produce 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=I3c1fed78475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
adenosine
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 triphosphate (\u8220\'3fATP\u8221\'3f), which aids cellular respiration. CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 assists ATP production through redox reactions, in which the coenzyme gives up and gains electrons. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Both oxidized and reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 are sold as dietary supplements.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_2_63}{\*\bkmkend co_pp_sp_999_2_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*2
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, which is owned by Kaneka, contains forty-five (45) process claims, of which four\u8212\'3fclaims 1, 11, 22, and 33\u8212\'3fare independent. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Decl. Lei Mei in Supp. Defs.\rquote  Mot. for Summ. J. (\u8220\'3fMei Opening Decl.\u8221\'3f), Ex. A (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f) col. 23, l. 55\u8211\'3fcol. 26, l. 65, ECF No. 559\u8211\'3f2; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defs.\rquote  Statement of Genuine Disputes of Material Fact in Response to Pl. Kaneka Corp.\rquote s Statement of Uncontroverted Facts and Conclusions of Law (\u8220\'3fDefs.\rquote  Response\u8221\'3f) \u182\'3f 1, ECF No. 604\u8211\'3f1.) Independent claim 22, which is asserted against Defendants, recites:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A process for producing on an industrial scale the oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 represented by the following formula ... which comprises culturing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms in a culture medium containing a carbon source, a nitrogen source, a phosphorous source and a micronutrient to obtain microbial cells containing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of not less than 70 mole % among the entire coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
,
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
disrupting the microbial cells to obtain reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
; and
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
oxidizing thus-obtained reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and then extracting the oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 by an organic solvent in a sealed tank.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 25, ll. 31\u8211\'3f54.) Independent claim 33, which is also asserted against Defendants, is identical to claim 1, except that (1) it does not contain a \u8220\'3fdisrupting\u8221\'3f step; and (2) the extraction step is recited before the oxidation step. (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 26, ll. 13\u8211\'3f36 [\u8220\'3fextracting the reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 by an organic solvent in a sealed tank, and oxidizing the extracted reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f].) Dependent claim 36, the final asserted claim, recites \u8220\'3f[t]he process according to claim 33, further comprising disrupting the microbial cells.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 26, ll. 42\u8211\'3f43.) Claims 22, 33, and 36 are collectively referred to as the \u8220\'3fasserted claims.\u8221\'3f
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1788301053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1788301053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1788301053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1788301053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
B. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
The Defendants
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
XKGC and Shenzhou (the \u8220\'3fManufacturing Defendants\u8221\'3f) are entities Kaneka accuses of directly infringing the asserted claims. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Second Am. Compl. (\u8220\'3fSAC\u8221\'3f), ECF No. 412.) Defendants PRI, Sojitz, and Rochem (the \u8220\'3fDistributor Defendants\u8221\'3f) are distributors of CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 produced by XKGC\rquote s manufacturing processes. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, SAC \u182\'3f 19.) They do not separately move for summary judgment on any issue. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defs.\rquote  Mot., ECF No. 559.) After the motions for summary judgment were filed, Kaneka settled its dispute with Shenzhou, Sojitz, and Rochem.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00012044683407_ID0EVOAC_63}{\*\bkmkend co_fnRef_B00012044683407_ID0EVOAC_63}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00012044683407_63" }{\fldrslt 
{\super \b0 \cf20 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
1
}}}
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia179e291053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia179e291053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia179e291053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia179e291053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
C. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
Procedural History
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The procedural history of this case is long and tortured. On March 22, 2011, Kaneka filed the instant action, which was initially assigned to Judge Mariana R. Pfaelzer, asserting infringement of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 against XKGC, PRI, Shenzhou, Zhejiang Medicine Co., Ltd. (\u8220\'3fZhejiang\u8221\'3f), ZMC\u8211\'3fUSA, L.L.C. (\u8220\'3fZMC\u8221\'3f), Maypro Industries, Inc. (\u8220\'3fMaypro\u8221\'3f), and Mitsubishi Gas Chemical Company, Inc. (\u8220\'3fMGC\u8221\'3f) (collectively, \u8220\'3fOriginal Defendants\u8221\'3f). (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Compl., ECF No. 1.) One day earlier, however, Zhejiang and ZMC filed a declaratory judgment action with respect to the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in the United States District Court for the Southern District of Texas (the \u8220\'3fTexas Litigation\u8221\'3f). 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Compl., 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040330620&pubNum=0004031&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Zhejiang Med. Co. et al. v. Kaneka Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, No. 4:11\u8211\'3fcv\u8211\'3f01052 (S.D. Tex. Mar. 21, 2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, ECF No. 1. On October 4, 2013, Kaneka filed an Amended Complaint against the Original Defendants. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Am. Compl., ECF No. 220.) Defendants filed separate Answers to the Amended Complaint on October 18, 2013. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Answers to Am. Compl., ECF Nos. 238\u8211\'3f240.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_3_63}{\*\bkmkend co_pp_sp_999_3_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*3
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 On June 17, 2011, Kaneka filed a Section 337 Petition in the United States International Trade Commission (\u8220\'3fITC\u8221\'3f) involving the same claims of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&pubNum=0001032&cite=USITCINVNO337-TA-790&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Certain Coenzyme Q10 Products and Methods of Making Same, Inv. No. 337\u8211\'3fTA\u8211\'3f790
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&pubNum=0007886&cite=USITCPUB4407&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
USITC Pub. 4407 (Sept. 27, 2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Final) (the \u8220\'3fITC Proceeding\u8221\'3f). Judge Pfaelzer stayed the instant action pending resolution of the ITC proceeding. (Orders and Corrected Order re Stipulation to Stay District Court Action, ECF Nos. 59\u8211\'3f61.) The ITC issued a decision finding no infringement by any of the respondents. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Joint Status Report, ECF No. 70.) The parties stipulated that all discovery taken in the ITC proceeding could be used in this case. (Joint Rule 26(f) Report 9, ECF No. 92; Stip. Protective Order, ECF No. 97.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On February 7, 2013, Judge Pfaelzer lifted the stay in the instant action, (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Joint Status Report), and on July 24, 2013, issued a Claim Construction Order, construing the following five terms:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia15320b0053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia15320b0053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
}
}
}
}
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \ltrrow \trleft0 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrt \clbrdrl \trql \clwWidth5040 \cellx5040 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrt \clbrdrr \trql \clwWidth5040 \cellx10080 
\intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
Claim Term
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\b0 \cf1 \f4 \ri36 \ul0 \strike0 \i0 \ql \li36 \fs24 \sa0 \sb0 \intbl \cell \intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
Claim Construction
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\b0 \cf1 \f4 \ri36 \ul0 \strike0 \i0 \ql \li36 \fs24 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrl \trql \clwWidth5040 \cellx5040 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrr \trql \clwWidth5040 \cellx10080 
\intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote inert gas atmosphere\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\b0 \cf1 \f4 \ri36 \ul0 \strike0 \i0 \ql \li36 \fs24 \sa0 \sb0 \intbl \cell \intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote a gas atmosphere that is free or substantially free of oxygen and reactive gases\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\b0 \cf1 \f4 \ri36 \ul0 \strike0 \i0 \ql \li36 \fs24 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrl \trql \clwWidth5040 \cellx5040 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrr \trql \clwWidth5040 \cellx10080 
\intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote sealed tank\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\b0 \cf1 \f4 \ri36 \ul0 \strike0 \i0 \ql \li36 \fs24 \sa0 \sb0 \intbl \cell \intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote a tank that is closed to prevent the entry or exit of materials\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\b0 \cf1 \f4 \ri36 \ul0 \strike0 \i0 \ql \li36 \fs24 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrl \trql \clwWidth5040 \cellx5040 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrr \trql \clwWidth5040 \cellx10080 
\intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote culturing reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 producing microorganisms ... to obtain microbial cells containing reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 at a ratio of not less than 70 mole % among the entire coenzymes 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
.\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\sub \b0 \cf1 \f4 \strike0 \i0 \fs24 \sa0 \sb0 \ri36 \ul0 \ql \li36 \intbl \cell \intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote culturing reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 producing microorganisms to obtain microbial cells containing reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 at a ratio of not less than 70 mole % among the entire coenzymes 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 at a time prior to the extraction, oxidation, or disruption steps and as determined by the assay described at col. 5, line 8 to line 43, and Example 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rquote 340 Patent
}\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
.\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\sub \b0 \cf1 \f4 \strike0 \i0 \fs24 \sa0 \sb0 \ri36 \ul0 \ql \li36 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrl \trql \clwWidth5040 \cellx5040 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrr \trql \clwWidth5040 \cellx10080 
\intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote oxidizing thus-obtained reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 to oxidized coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\sub \b0 \cf1 \f4 \strike0 \i0 \fs24 \sa0 \sb0 \ri36 \ul0 \ql \li36 \intbl \cell \intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote actively converting all or substantially all of the reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 obtained from the disruption step to oxidized coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 in a step before beginning the extraction step\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\sub \b0 \cf1 \f4 \strike0 \i0 \fs24 \sa0 \sb0 \ri36 \ul0 \ql \li36 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrb \clbrdrl \trql \clwWidth5040 \cellx5040 
\clpadt36 \clpadft3 \clpadr36 \clpadfr3 \clbrdrb \clbrdrr \trql \clwWidth5040 \cellx10080 
\intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote oxidizing the extracted reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 to oxidized coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\sub \b0 \cf1 \f4 \strike0 \i0 \fs24 \sa0 \sb0 \ri36 \ul0 \ql \li36 \intbl \cell \intbl 
{\ri36 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ri36 \i0 \ql \fs24 \li36 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\rdblquote actively converting all or substantially all of the extracted reduced coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 obtained from the disruption step to oxidized coenzyme 
}
{\b0 \cf1 \f4 \i0 \fs20 
{\sub \b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
 in a separate step after the extraction step has been performed\rdblquote 
\par 
}
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
\u160\'3f
\par 
}
}
}\sub \b0 \cf1 \f4 \strike0 \i0 \fs24 \sa0 \sb0 \ri36 \ul0 \ql \li36 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb300 
 Claim Construction Order, ECF No.155) Shortly thereafter, on August 27, 2013, XKGC, PRI, and Shenzhou moved for summary judgment of noninfringement based upon the Court\rquote s constructions and discovery taken in the ITC Proceeding. (Defs.\rquote  Mots. for Summ. J. as to Noninfringement, ECF Nos. 158, 188.) Kaneka, meanwhile, moved for summary judgment with respect to validity and to certain of XKGC\rquote s counterclaims on November 12, 2013. (Pl.\rquote s Mots for Summ. J., ECF Nos. 265\u8211\'3f266.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Judge Pfaelzer granted in part XKGC, PRI, and Shenzhou\rquote s summary judgment motions on December 6, 2013, finding that no genuine dispute of material fact existed as to whether Movants\rquote  \u8220\'3fcell paste drying step,\u8221\'3f \u8220\'3fbiomass drying step,\u8221\'3f and \u8220\'3falkali wash\u8221\'3f practice the limitations of the independent claims, or whether Shenzhou\rquote s process includes an oxidation step after the extraction step as required by Claims 11 and 33. (Orders Granting in Part Defs.\rquote  Mots. for Summ. J., ECF Nos. 310\u8211\'3f311.) On February 24, 2014, Judge Pfaelzer denied Kaneka\rquote s motion for summary judgment regarding validity but granted its motion with respect to XKGC\rquote s third through ninth counterclaims. (Order Granting in Part and Den. in Part Pl.\rquote s Mots. for Summ. J., ECF Nos. 313\u8211\'3f314
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On March 27, 2014, Judge Pfaelzer entered judgment in favor of XKGC, PRI, and Shenzhou, and dismissed without prejudice these defendants\rquote  counterclaims for declaratory judgment of invalidity and unenforceability. (Judgment, ECF No. 322.) This judgment was appealed by Kaneka to the United States Court of Appeals for the Federal Circuit, which issued an opinion affirming in part, vacating in part, and remanding the action to the district court on June 10, 2015. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036432113&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Kaneka Corp. v. Xiamen Kingdomway Grp. Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 790 F.3d 1298 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fOpinion\u8221\'3f). In particular, the Federal Circuit (1) upheld Judge Pfaelzer\rquote s grant of summary judgment of noninfringement of independent claims 1 and 11 and dependent claims 8\u8211\'3f9 and 19\u8211\'3f20; and (2) vacated Judge Pfaelzer\rquote s grant of summary judgment of noninfringement of independent claims 22 and 33 and associated depending claims. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Opinion. With respect to the latter conclusion, the Federal Circuit held (1) that Judge Pfaelzer\rquote s construction of the term \u8220\'3fsealed tank\u8221\'3f conflicted with the intrinsic record, and construed the term to mean \u8220\'3fa tank that prevents exposure of the tank\rquote s contents to the atmosphere,\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036432113&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1305&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1305" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1305
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; and (2) that the oxidizing step \u8220\'3frequires some action that results in oxidation but does not require oxidation of \lquote all or substantially all\rquote  of the coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,\rquote \u8221\'3f and that \u8220\'3fit is not required that any one step be carried out separately or independently of any other step,\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036432113&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1307&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1307" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1307
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_4_63}{\*\bkmkend co_pp_sp_999_4_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*4
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The instant action was remanded and subsequently reassigned from Judge Pfaelzer to Judge Cristina A. Snyder. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Notice of Reassignment of Case, ECF No. 354.) XKGC and PRI then filed a second motion for summary judgment (\u8220\'3fSecond XKGC Motion\u8221\'3f) on October 26, 2015. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Mot. for Summ. J. as to Invalidity and Noninfringement, ECF No. 355.) On January 6, 2016, the parties consented to having the action referred to the Patent Pilot Program (\u8220\'3fPPP\u8221\'3f) pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2026167096&pubNum=0004031&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
General Order No. 11\u8211\'3f11
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Joint Notice of Consent to Referral to the PPP, ECF No. 394.) On March 15, 2016, this Court issued a minute order in which it (1) set a scheduling conference; and (2) denied without prejudice the Second XKGC Motion in light of the need for additional discovery given the Federal Circuit\rquote s construction of certain terms and the passage of time. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order Setting Scheduling Conference, ECF No. 399.) At the scheduling conference, the Court imposed deadlines regarding the filing of amended pleadings, the exchange of final infringement and final invalidity contentions, and the filing of dispositive motions. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Minutes of Scheduling Conference, ECF No. 405.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka filed its SAC on May 2, 2016, naming Sojitz and Rochem as additional defendants. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 SAC.) On September 16, 2016, Kaneka served its final infringement contentions on Defendants, asserting infringement of claims 22, 33, and 36. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Pl. Kaneka Corp.\rquote s Am. Patent L.R. 3\u8211\'3f1 (N.D. Cal) Disclosure of Asserted Claims and Second Am., Final Infringement Contentions (\u8220\'3fKaneka\rquote s FICs\u8221\'3f), ECF No. 518.) The parties\rquote  cross-motions for summary judgment followed.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
On February 22, 2017, the Court ruled on three of the parties\u8217\'3f four 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Motions, (1) denying Kaneka\rquote s Motion in Limine No. 1 to Preclude Admission of Portions of the Expert Report and Testimony of Shirley Webster, (2) granting-in-part and denying-in-part Kaneka\rquote s Motion in Limine No. 2 to Preclude Admission of Portions of Reports on Defendants\u8217\'3f Infringement and Invalidity Experts and Related Testimony, and (3) granting-in-part and denying-in-part Defendants\u8217\'3f Motion in Limine No. 1 to Exclude the Testimony of David Sherman, PhD. (Minute Order (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Order\u8221\'3f), ECF No. 696.) Following the entry of this Order, but before the Court ruled on the pending cross-motions for summary judgment, the parties entered into a period of settlement negotiations during which the action was stayed. On October 5, 2017, Kaneka, XKGC, and PRI informed the Court that they were unable to reach a settlement and the Court set a trial date. (Joint Motion for Pretrial Conference Date, ECF No. 780; Order Granting Joint Motion, ECF No. 781.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia18490f1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia18490f1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia18490f1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia18490f1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
II. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
LEGAL FRAMEWORK
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia18490f1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia18490f1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
Overview of the Parties\rquote  Arguments
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants first move for summary judgment of invalidity, contending (1) the asserted claims are indefinite under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. section 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 2 (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 2\u8221\'3f) because the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 does not teach, and persons skilled in the art did not know, how to properly collect and handle samples for testing the mole percentage; and (2) the asserted claims are invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f) for claiming a natural phenomenon combined with conventional steps. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Mem. of Ps & As in Supp. Defs.\rquote  Mot (\u8220\'3fDefs.\rquote  Mem.\u8221\'3f) 9\u8211\'3f24, ECF No. 561\u8211\'3f1.) Defendants also move for summary judgement of noninfringement, arguing no Defendant infringes any of the asserted claims, either literally or under the doctrine of equivalents (\u8220\'3fDOE\u8221\'3f), because (1) Defendants do not culture \u8220\'3freduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms,\u8221\'3f which cannot be photosynthetic bacteria; (2) Kaneka\rquote s own test results show XKGC does not produce reduced Co Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of \u8220\'3fnot less than 70 mole %\u8221\'3f at the end of the \u8220\'3ffermentation\u8221\'3f or \u8220\'3fculturing\u8221\'3f step; (3) Defendants do not use a \u8220\'3fsealed tank\u8221\'3f during extraction; and (4) Defendants\rquote  processes do not perform an active \u8220\'3foxidizing\u8221\'3f step prior to extraction. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Mem. 25\u8211\'3f
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.)
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka, meanwhile, moves for summary judgement of validity, arguing the asserted claims (1) are not indefinite under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 2; (2) are patent-eligible under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; and (3) are not anticipated by any of Defendants\rquote  cited prior art references under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. section 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f). (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Mem. of Ps & As in Supp. Kaneka Mot. (\u8220\'3fKaneka Mem.\u8221\'3f), ECF No. 556\u8211\'3f1.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1868cc1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1868cc1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1868cc1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1868cc1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
B. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
Relevant Legal Standards
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Summary Judgment
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_5_63}{\*\bkmkend co_pp_sp_999_5_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*5
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR56&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal Rule of Civil Procedure 56(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 mandates that \u8220\'3f[t]he court shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR56&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Fed. R. Civ. P. 56(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The moving party bears the initial burden of establishing the absence of a genuine issue of material fact. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132677&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_323&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_323" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Celotex Corp. v. Catrett
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 477 U.S. 317, 323, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fWhen the party moving for summary judgment would bear the burden of proof at trial, it must come forward with evidence which would entitle it to a directed verdict if the evidence went uncontroverted at trial. In such a case, the moving party has the initial burden of establishing the absence of a genuine issue of fact on each issue material to its case.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2000358465&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_480&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_480" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
C.A.R. Transp. Brokerage Co. v. Darden Rests., Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 213 F.3d 474, 480 (9th Cir. 2000)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citations omitted). In contrast, when the nonmoving party bears the burden of proving the claim or defense, the moving party does not need to produce any evidence or prove the absence of a genuine issue of material fact. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132677&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_325&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_325" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Celotex
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 477 U.S. at 325, 106 S.Ct. 2548
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Rather, the moving party\rquote s initial burden \u8220\'3fmay be discharged by \lquote showing\rquote \u8212\'3fthat is, pointing out to the district court\u8212\'3fthat there is an absence of evidence to support the nonmoving party\rquote s case.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132677&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3fSummary judgment for a defendant is appropriate when the plaintiff \lquote fails to make a showing sufficient to establish the existence of an element essential to [his] case, and on which [he] will bear the burden of proof at trial.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999127159&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_805&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_805" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Cleveland v. Policy Mgmt. Sys. Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 526 U.S. 795, 805\u8211\'3f06, 119 S.Ct. 1597, 143 L.Ed.2d 966 (1999)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132677&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_322&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_322" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Celotex
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 477 U.S. at 322, 106 S.Ct. 2548
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Once the moving party meets its initial burden, the \u8220\'3fparty asserting that a fact cannot be or is genuinely disputed must support the assertion.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR56&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Fed. R. Civ. P. 56(c)(1)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fThe mere existence of a scintilla of evidence in support of the [nonmoving party]\rquote s position will be insufficient; there must be evidence on which the jury could reasonably find for the [nonmoving party].\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_252&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_252" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Anderson v. Liberty Lobby, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 477 U.S. 242, 252, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
accord
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986115992&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_586&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_586" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Matsushita Elec. Indus. Co. v. Zenith Radio Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 475 U.S. 574, 586, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f[O]pponent must do more than simply show that there is some metaphysical doubt as to the material facts.\u8221\'3f). Further, \u8220\'3f[o]nly disputes over facts that might affect the outcome of the suit ... will properly preclude the entry of summary judgment [and f]actual disputes that are irrelevant or unnecessary will not be counted.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_248&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_248" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Liberty Lobby
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 477 U.S. at 248, 106 S.Ct. 2505
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. At the summary judgment stage, a court does not make credibility determinations or weigh conflicting evidence. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_249&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_249" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 249, 106 S.Ct. 2505
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. A court is required to draw all inferences in a light most favorable to the nonmoving party. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986115992&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_587&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_587" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Matsushita
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 475 U.S. at 587, 106 S.Ct. 1348
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia18a3641053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia18a3641053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Definiteness Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
 \u182\'3f 2 and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul1 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus v. Biosig
}
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fThe Patent Act requires that a patent specification \lquote conclude with one or more claims 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
particularly pointing out and distinctly claiming
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the subject matter which the applicant regards as [the] invention.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2124&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2124" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus, Inc. v. Biosig Instruments, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 134 S.Ct. 2120, 2124, 189 L.Ed.2d 37 (2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (emphasis in original) (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u182\'3f 2 (2006 ed.)). In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the United States Supreme Court overturned the Federal Circuit\rquote s formulation that a patent claim passes muster under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 2 (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 2\u8221\'3f) so long as the claim is \u8220\'3famenable to construction,\u8221\'3f and the claim, as construed, is not \u8220\'3finsolubly ambiguous,\u8221\'3f concluding that such a test \u8220\'3fdoes not satisfy the statute\rquote s definiteness requirement.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030433973&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_898&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_898" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Biosig Instruments, Inc. v. Nautilus, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 715 F.3d 891, 898\u8211\'3f99 (Fed. Cir. 2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
judgment vacated
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 134 S.Ct. 2120, 189 L.Ed.2d 37
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Instead, the Supreme Court held that a patent is invalid for indefiniteness \u8220\'3fif its claims, read in light of the specification delineating the patent, and the prosecution history, fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030433973&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Definiteness is measured from the viewpoint of a person skilled in the art at the time the patent was filed. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2128&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2128" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 2128
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The definiteness requirement must take into account the inherent limitations of language, as \u8220\'3f[s]ome modicum of uncertainty ... is the \lquote price of ensuring the appropriate incentives for innovation.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030433973&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_732&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_732" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo VIII
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f), 535 U.S. 722, 732, 122 S.Ct. 1831, 152 L.Ed.2d 944 (2002)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Notwithstanding these inherent limitations, \u8220\'3fa claim is indefinite if its language \lquote might mean several different things and no informed and confident choice is available among the contending definitions.\rquote 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2037077793&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1371&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1371" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Media Rights Techs., Inc. v. Capital One Fin. Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 800 F.3d 1366, 1371 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2130&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2130" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2130 n.8
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_6_63}{\*\bkmkend co_pp_sp_999_6_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*6
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Indefiniteness is a question of law that may be decided at the summary judgment stage. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva Pharms. USA, Inc. v. Sandoz, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 789 F.3d 1335, 1341 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035591098&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1364&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1364" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Eidos Display, LLC v. AU Optronics Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 779 F.3d 1360, 1364 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia18db8b1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia18db8b1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
3. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Patent\u8211\'3fEligibility Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 defines the subject matter that may be patented under the Patent Act.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022394590&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_601&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_601" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Bilski v. Kappos
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 561 U.S. 593, 601, 130 S.Ct. 3218, 177 L.Ed.2d 792 (2010)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 reads in its entirety: \u8220\'3fWhoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 thus specifies four independent categories of inventions or discoveries that are eligible for protection: processes, machines, manufactures, and compositions of matter.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2022394590&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_601&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_601" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Bilski
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 561 U.S. at 601, 130 S.Ct. 3218
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Although acknowledging that \u8220\'3f[i]n choosing such expansive terms ... Congress plainly contemplated that the patent laws would be given wide scope,\u8221\'3f the Supreme Court long ago identified three exceptions to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
: \u8220\'3flaws of nature, physical phenomena, and abstract ideas.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1980116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_308&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_308" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Diamond v. Chakrabarty
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 447 U.S. 303, 308\u8211\'3f09, 100 S.Ct. 2204, 65 L.Ed.2d 144 (1980)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Although these exceptions are not required by the statutory text, they are consistent with the idea that certain discoveries \u8220\'3fare part of the storehouse of knowledge of all men\u8221\'3f and are \u8220\'3ffree to all men and reserved exclusively to none.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_130&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_130" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Funk Bros. Seed Co. v. Kalo Inoculant Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 333 U.S. 127, 130, 68 S.Ct. 440, 92 L.Ed. 588 (1948)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Thus, \u8220\'3fthe concern that drives this exclusionary principle [is] one of pre-emption.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice Corp. Pty. Ltd. v. CLS Bank Int\rquote l
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 134 S.Ct. 2347, 2354, 189 L.Ed.2d 296 (2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Consequently, the Supreme Court has required that \u8220\'3f[i]f there is to be invention from such a discovery, it must come from the application of the law of nature to a new and useful end.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_130&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_130" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Funk Bros.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 333 U.S. at 130, 68 S.Ct. 440
}}}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 These principles have been held to apply with equal force to product and process claims. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1972137547&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_67&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_67" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Gottschalk v. Benson
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 409 U.S. 63, 67\u8211\'3f68, 93 S.Ct. 253, 34 L.Ed.2d 273 (1972)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Supreme Court has articulated a two-part test for distinguishing patents that claim one of the patent-ineligible exceptions from those that claim patent-eligible applications of those concepts. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2354
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fStep one asks whether the claim is \lquote directed to one of [the] patent-ineligible concepts.\rquote \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Rapid Litig. Mgmt. Ltd. v. CellzDirect, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d 1042, 1047 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2354
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). \u8220\'3fIf the answer is no, the inquiry is over: the claim falls within the ambit of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3fIf the answer is yes, the inquiry moves to step two, which asks whether, considered both individually and as an ordered combination, \lquote the additional elements \u8220\'3ftransform the nature of the claim\u8221\'3f into a patent-eligible application.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2354
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Step two is described \u8220\'3fas a search for an \lquote inventive concept.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2354
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_72&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_72" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo Collaborative Servs. v. Prometheus Labs, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 566 U.S. 66, 72, 132 S.Ct. 1289, 182 L.Ed.2d 321 (2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). \u8220\'3fAt step two, more is required than \lquote well-understood, routine, conventional activity already engaged in by the scientific community,\rquote  which fails to transform the claim into \lquote significantly more than a patent upon the\rquote 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ineligible concept itself.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d at 1047
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_73&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_73" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 566 U.S. at 73, 132 S.Ct. 1289
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). \u8220\'3fWhile patent eligibility is ultimately a question of law ... [w]hether something is well-understood, routine, and conventional to a skill artisan at the time of the patent is a factual determination.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2043776259&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1369&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1369" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Berkheimer v. HP, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 881 F.3d 1360, 1369 (Fed. Cir. 2018)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia192c1c1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia192c1c1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
4. Anticipation and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_a83b000018c76" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 102(b)
}}}
\sa200 
\sb400 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb400 
\rquote s Public Use/On\u8211\'3fSale Bar
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_7_63}{\*\bkmkend co_pp_sp_999_7_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*7
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_8b3b0000958a4" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. Section 102(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_8b3b0000958a4" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 102(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), \u8220\'3f[a] person shall be entitled to a patent unless ... the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. ...\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_7b9b000044381" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 102(a)(1)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fIt is well settled that a claim is anticipated if each and every limitation is found either expressly or inherently in a single prior art reference.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998151585&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1361&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1361" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Celeritas Techs., Ltd. v. Rockwell Int\rquote l Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 150 F.3d 1354, 1361 (Fed. Cir. 1998)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1984153089&pubNum=0000350&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_350_715&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_350_715" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Structural Rubber Prods. Co. v. Park Rubber Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 749 F.2d 707, 715 (Fed. Cir. 1984)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_a83b000018c76" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. Section 102(b)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_a83b000018c76" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 102(b)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), \u8220\'3f[a] person shall be entitled to a patent unless ... the invention was in public use or on sale in this country, more than one year prior to the date of the application for patent in the United States. ...\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_a83b000018c76" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 102(b)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fWhen the asserted basis of invalidity is a public use or on-sale bar, the court should determine \lquote whether the subject of the barring activity met each of the limitations of the claim, and thus was an embodiment of the claimed invention.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002122512&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1375&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1375" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dana Corp. v. Am. Axle & Mfg., Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 279 F.3d 1372, 1375\u8211\'3f76 (Fed. Cir. 2002)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1999134122&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1383&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1383" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Scaltech Inc. v. Retec/Tetra, L.L.C.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 178 F.3d 1378, 1383 (Fed. Cir. 1999)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
); 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2005805817&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1256&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1256" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re Crish
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 393 F.3d 1253, 1256 (Fed. Cir. 2004)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia194e4a1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia194e4a1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
5. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Literal Infringement
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fAn infringement analysis entails two steps. The first step is determining the meaning and scope of the patent claims asserted to be infringed. The second step is comparing the properly construed claims to the device accused of infringing.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_976&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_976" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman v. Westview Instruments, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 52 F.3d 967, 976 (Fed. Cir. 1995)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (en banc), 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
aff\rquote d
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1996098750&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fTo establish liability for direct infringement of a claimed method or process under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS271&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_8b3b0000958a4" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 271(a)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, a patentee must prove that each and every step of the method or process was performed.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2029974755&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1122&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1122" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Move, Inc. v. Real Estate Alliance Ltd.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 709 F.3d 1117, 1122 (Fed. Cir. 2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2028515276&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1307&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1307" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Akamai Techs., Inc. v. Limelight Networks, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 692 F.3d 1301, 1307 (Fed. Cir. 2012)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (en banc)). To establish literal infringement of a process claim, the enumerated steps must \u8220\'3fall be practiced as recited in the claim ...\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2011431040&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1343&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1343" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dippin\rquote  Dots, Inc. v. Mosey
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 476 F.3d 1337, 1343 (Fed. Cir. 2007)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3f[A]ny deviation from the claim precludes a finding of literal infringement.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024956925&pubNum=0000999&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Jardin v. Datallegro, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, No. 08-CV-1462-IEG (WVG), 2011 WL 1311732, at *3
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998083439&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1454&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1454" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Litton Sys. Inc. v. Honeywell, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 140 F.3d 1449, 1454 (Fed. Cir. 1998)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
abrogated by
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2000627613&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., Ltd.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 234 F.3d 558 (2000)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The patentee bears the ultimate burden of proving infringement by a preponderance of the evidence, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
see
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2007113614&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Warner\u8211\'3fLambert Co. v. Teva Pharm. USA, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 418 F.3d 1326, 1341 n.15 (Fed. Cir. 2005)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and as a result, summary judgment of noninfringement requires a showing by the accused infringer that \u8220\'3fno reasonable jury could have found infringement on the undisputed facts or when all reasonable factual inferences are drawn in favor of the patentee,\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2001224511&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1353&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1353" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Netword, LLC v. Centraal Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 242 F.3d 1347, 1353 (Fed. Cir. 2001)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia197a3c1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia197a3c1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
6. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Infringement Under the \u8220\'3fDoctrine of Equivalents\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A process that does not literally infringe a patent claim may nevertheless be found to infringe under the \u8220\'3fdoctrine of equivalents.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2025751541&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1380&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1380" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Duramed Pharm., Inc. v. Paddock Labs., Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 644 F.3d 1376, 1380 (Fed. Cir. 2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fTo find infringement under the doctrine of equivalents, any differences between the claimed invention and the accused product must be insubstantial.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2029902769&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1346&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1346" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Brilliant Instruments, Inc. v. GuideTech, LLC
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 707 F.3d 1342, 1346 (Fed. Cir. 2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1950117294&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_608&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_608" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Graver Tank & Mfg. Co. v. Linde Air Prods. Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 339 U.S. 605, 608, 70 S.Ct. 854, 94 L.Ed. 1097 (1950)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). \u8220\'3fOne way of proving infringement under the doctrine of equivalents is to show, for each claim limitation, that the accused product \lquote performs substantially the same function in substantially the same way with substantially the same result as each claim limitation of the patented product.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2029902769&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1347&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1347" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1347
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018376529&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1312&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1312" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Crown Packaging Tech., Inc. v. Rexam Beverage Can Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 559 F.3d 1308, 1312 (Fed. Cir. 2009)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). This is a question of fact. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018376529&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 (citations omitted).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_8_63}{\*\bkmkend co_pp_sp_999_8_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*8
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The DOE contains a number of inherent limitations. For example, \u8220\'3f[i]f the claimed and accused elements are recognized by those of skill in the art to be opposing ways of doing something, they are likely not insubstantially different.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2029902769&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1347&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1347" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1347\u8211\'3f48
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Moreover, \u8220\'3fthe doctrine of prosecution history estoppel prevents a patent owner from recapturing through the doctrine of equivalents subject matter surrendered to acquire the patent.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2025751541&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1380&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1380" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Duramed
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 644 F.3d at 1380
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. If the patentee narrowed the scope of the asserted patent\rquote s claims in response to a prior art rejection, a presumption of prosecution history estoppel applies, which may be rebutted by showing, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
inter alia
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the \u8220\'3falleged equivalent would have been \lquote unforeseeable at the time of the amendment and thus beyond a fair interpretation of what was surrendered.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003658735&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1369&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1369" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo IX
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), 344 F.3d 1359, 1369 (Fed. Cir. 2003)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_738&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_738" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo VIII
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 535 U.S. at 738, 122 S.Ct. 1831
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). This is commonly referred to as \u8220\'3fargument-based estoppel.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2009742933&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1363&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1363" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Conoco, Inc. v. Energy & Envtl. Int\rquote l, L.C.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 460 F.3d 1349, 1363 (Fed. Cir. 2006)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. Similarly, a patentee\rquote s argument to the patent examiner distinguishing a claim from the prior art\u8212\'3freferred to as \u8220\'3famendment-based estoppel\u8221\'3f\u8212\'3fcan curtail the application of the DOE. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2009742933&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia19aff21053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia19aff21053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia19aff21053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia19aff21053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
III. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
DISCUSSION
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia19aff21053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia19aff21053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Whether the \u8220\'3f70 Mole %\u8221\'3f Limitation Is Indefinite Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
\sb200 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
 \u182\'3f 2
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
The Parties\rquote  Arguments
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants first contention is that \u8220\'3fculturing\u8221\'3f step recited in the asserted claims\u8212\'3f\u8220\'3fculturing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 producing microorganisms ... to obtain microbial cells containing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of not less than 70 mole % among the entire coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f (the \u8220\'3f70 mole % limitation\u8221\'3f)\u8212\'3fis indefinite under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u182\'3f 2 and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Defs.\rquote  Mem. 9\u8211\'3f16.) In particular, Defendants contend the record makes clear that those skilled in the art, such as the parties\rquote  technical experts, did not know, with reasonable certainty, how the molarity of the pre-extracted sample should be measured during the ITC Proceeding. (Defs.\rquote  Mem. 10\u8211\'3f12.) The parties agree that measurement of the mole % ratio requires several steps\u8212\'3ffirst 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
collecting
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 a sample, then 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
handling
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (e.g., storing) the sample, and finally 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
testing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the sample. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Response to Defs.\rquote  Statement of Uncontroverted Facts and Conclusions of Law (\u8220\'3fKaneka\rquote s Response\u8221\'3f) \u182\'3f 13, ECF No. 608\u8211\'3f1.) 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants argue that although the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 identifies a preferred 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
testing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 method in the specification, it is silent as to how the sample should be 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
collected
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
handled
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 before being tested in a lab, and submit that the parties\rquote  experts\rquote  disagreements regarding how to collect and handle samples during the ITC Proceeding highlight the indefiniteness of this limitation. ( Defs.\rquote  Mem. 10\u8211\'3f12.) In particular, Defendants point to language in the Claim Construction Order indicating that, during the ITC proceeding, \u8220\'3f[e]ach party argued that the other party\rquote s method of testing [molarity] was erroneous,\u8221\'3f supporting the conclusion that those skilled in the art did not know the scope of the asserted claims with reasonable certainty. (Defs.\rquote  Mem. 11\u8211\'3f12 [citing Claim Construction Order at pgs. 12, 12 n.3].)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka, in turn, contends that Defendants should be barred, both procedurally and as a matter of law, from arguing the 70 mole % limitation is indefinite, characterizing this effort as \u8220\'3fan improper request for reconsideration of this court\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 ruling.\u8221\'3f (Kaneka Mem. 8.) Kaneka further submits that Defendants\rquote  own experts testified before the ITC that a person of ordinary skill in the art would understand the proper methods of sample collection, preservation, and testing, and therefore Kaneka should be entitled to summary judgment on this issue. (Kaneka Mem. 10\u8211\'3f12.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia19e3371053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia19e3371053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
The Challenged 70 Mole % Claim Limitation
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
In her Claim Construction Order, Judge Pfaelzer construed the 70 mole % limitation as follows:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
culturing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 producing microorganisms to obtain microbial cells containing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
not less than 70 mole %
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 among the entire coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
at a time prior to the extraction, oxidation, or disruption steps
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
as determined by the assay described
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
col. 5, line 8 to line 43
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Example 1
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_9_63}{\*\bkmkend co_pp_sp_999_9_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*9
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Claim Construction Order 13 [emphasis added].) In construing the 70 mole % limitation in this manner, Judge Pfaelzer noted that \u8220\'3fany requirement as to the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
timing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the mole percent determination or the method of mole percent determination must be considered carefully and incorporated [into the claims from the specification] only if justified from the claim itself.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 11 [emphasis added].) She then found that although the \u8220\'3fclaims do not explicitly state a timing requirement for the mole percent determination ..., due to the structure of the claims, there is an implicit limitation ... [that] requires that the steps be performed in the order listed,\u8221\'3f and therefore \u8220\'3fthe mole percent of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 must be determined at a time prior to the execution of any of the subsequent steps of the claims.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 11\u8211\'3f12.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Judge Pfaelzer further noted that although the claims \u8220\'3fdo not explicitly state a 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
specific method of testing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to determine the percent of the reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,\u8221\'3f the method of testing is \u8220\'3f
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
critical
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ... to the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
determination of infringement
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 12 [emphasis added].) Judge Pfaelzer then acknowledged that the 70 mole % limitation was not construed in the ITC proceeding, and found that Kaneka\rquote s position taken during claim construction that no construction of the term is necessary would \u8220\'3fleave[ ] the claim so ambiguous that a person of ordinary skill in the art at the time of the invention could not understand it.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 12\u8211\'3f13.) Judge Pfaelzer \u8220\'3fresolve[d] this ambiguity\u8221\'3f by taking guidance from the specification, which \u8220\'3fprovides a \lquote demonstrated\rquote  method to \lquote standardize\rquote  the determination of the ratio of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 13.) In taking such guidance, Judge Pfaelzer expressly relied on the Federal Circuit\rquote s decision in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Biosig
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 at 13.) Judge Pfaelzer did not find the 70 mole % limitation to be indefinite in her Claim Construction Order.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
As noted above, however, the Supreme Court vacated the Federal Circuit\rquote s decision in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Biosig
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 approximately one year after Judge Pfaelzer issued her Claim Construction Order, expressly overturning the Federal Circuit\rquote s \u8220\'3finsolubly ambiguous\u8221\'3f standard and fashioning a new test that asks whether the claims, \u8220\'3fread in light of the specification delineating the patent, and the prosecution history, fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2124&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2124" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2124
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. Thus, the question the Court must decide is whether the 70 mole % limitation, as construed by Judge Pfaelzer in her Claim Construction Order, when read in light of the specification and prosecution history, fails to inform, with reasonable certainty, those skilled in the art about the scope of the invention.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1a5ad81053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1a5ad81053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
3. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
The ITC Proceedings
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The parties do not genuinely dispute that the following events occurred during the ITC proceeding. First, each party\rquote s expert
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00022044683407_ID0E3EAI_63}{\*\bkmkend co_fnRef_B00022044683407_ID0E3EAI_63}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00022044683407_63" }{\fldrslt 
{\super \b0 \cf20 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
2
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 admitted the amount of oxygen available to the cells during storage affects the ratio of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in a sample. (Mei Opening Decl., Ex. N (\u8220\'3fALJ Decision\u8221\'3f) at 227, ECF No. 561\u8211\'3f3.) Moreover, a microorganism\rquote s ability to metabolize oxygen was found to vary depending on whether samples were refrigerated or frozen, as evidenced by Kaneka\rquote s expert\rquote s testimony that although microorganisms continue to metabolize oxygen when refrigerated, \u8220\'3ffreezing causes microorganisms\rquote  metabolisms to slow greatly, or even go into a resting state.\u8221\'3f (ALJ Decision 228.) In fact, Kaneka\rquote s expert tested the impact of these two storage methods, and concluded that \u8220\'3fafter one to one and one-half days of refrigeration,\u8221\'3f 70.5% reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 was found in samples, while the amount of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 found in samples frozen during this same time period varied between 61.30% and 64.63%. (ALJ Decision 228\u8211\'3f229.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_10_63}{\*\bkmkend co_pp_sp_999_10_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 How long a sample was stored prior to measurement was also found to impact the molarity of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in the samples. Kaneka\rquote s expert testified that the results from tests performed \u8220\'3fon a refrigerated sample shortly after sampling\u8221\'3f and a second test performed 30 days later \u8220\'3fshowed an increase from 70.5% reduced [CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
] to over 90% reduced [CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
] over those 30 days.\u8221\'3f (ALJ Decision 228.) Moreover, Shenzhou conducted duplicative testing on its own refrigerated samples, finding that a mid-culture sample taken 63 hours into fermentation from its fermentation tanks contained 68% reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. (ALJ Decision 229.) Shenzhou\rquote s test results were challenged by Kaneka, which argued to the ALJ that a \u8220\'3fsingle mid-culture sample\u8221\'3f cannot be used to show noninfringement. (ALJ Decision 229.) The ALJ rejected this argument, noting that Kaneka relied upon the same sample point\u8212\'3f63 hours, which Kaneka\rquote s expert captioned \u8220\'3fLate Fermentation\u8221\'3f\u8212\'3fto show infringement. (ALJ Decision 229.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1a81e81053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1a81e81053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
4. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
The Federal Circuit\rquote s Opinions in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul1 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2007113614&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul1 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
, and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1998083439&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul1 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}}}
\sa200 
\sb400 
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants principally rely on three Federal Circuit opinions in support of their indefiniteness arguments: (1) 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow Chemical Co. v. Nova Chemicals Corp. (Canada)
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f), 803 F.3d 620 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; (2) 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f), 789 F.3d 1335 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; and (3) 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell International, Inc. v. International Trade Commission
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f), 341 F.3d 1332 (Fed. Cir. 2003)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defs\rquote  Mem. 9\u8211\'3f17.) A careful review of these decisions is critical to resolving the parties\rquote  definiteness dispute.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit found the claim term \u8220\'3fslope of strain hardening coefficient\u8221\'3f indefinite in light of (1) a lack of guidance in the claims, specification, and prosecution history as to how a person of ordinary skill in the art should calculate this coefficient; and (2) the fact that the patentee\rquote s own expert\rquote s \u8220\'3fchosen method\u8221\'3f for calculating this coefficient \u8220\'3fwas not even an established method but rather one developed for this particular case.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_634&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_634" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 803 F.3d at 634\u8211\'3f
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the patentee\rquote s expert testified at trial that \u8220\'3fone of ordinary skill in the art would know that the slope of the hardening curve would have to be measured at its 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
maximal value
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_633&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_633" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 633
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (emphasis added). \u8220\'3f[T]hree methods existed to determine the maximum slope,\u8221\'3f however, which each provided \u8220\'3fa different way of determining the maximum slope.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Moreover, the patentee\rquote s expert \u8220\'3fdeveloped yet another method\u8212\'3fof his own invention\u8212\'3fto calculate the slope of strain hardening.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Federal Circuit noted that \u8220\'3f[b]ecause the methods do not always produce the same results, the method chosen for calculating the slope of strain hardening could affect whether or not a given product infringes the claims.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_634&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_634" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 634
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit compared the facts in the case before it to those in another decision, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, which had issued just two months earlier. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_634&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_634" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 803 F.3d at 634\u8211\'3f
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the challenged claim limitation recited the term \u8220\'3fmolecular weight,\u8221\'3f but three relevant measures for molecular weight were known to exist\u8212\'3fnamely, peak average molecular weight (\u8220\'3fM
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
p
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f), number average molecular weight (\u8220\'3fM
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
n
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f), and weight average molecular weight (\u8220\'3fM
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
w
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f)\u8212\'3fwhere each was calculated in a different manner and each typically had a different value. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1338&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1338" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 789 F.3d at 1338
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Federal Circuit looked to \u8220\'3fthe patent record\u8212\'3fthe claims, specification, and prosecution history\u8212\'3fto ascertain if they convey to one of skill in the art with reasonable certainty the scope of the invention claimed.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1341
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The court found that neither the claims nor the specification contained an explicit definition of molecular weight, and also noted that the prosecution history contained inconsistent statements. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1342&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1342" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1342\u8211\'3f45
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The court therefore concluded that the claims were indefinite under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, notwithstanding the patentee\rquote s expert\rquote s testimony that someone skilled in the art could determine which method was the most appropriate. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1338&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1338" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1338, 1341, 1344\u8211\'3f45
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_11_63}{\*\bkmkend co_pp_sp_999_11_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*11
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Finally, in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit upheld a finding that the claim term \u8220\'3fmelting point elevation\u8221\'3f (\u8220\'3fMPE\u8221\'3f) was indefinite under the pre\u8211\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3finsolubly ambiguous\u8221\'3f standard, where neither the patent\rquote s written description nor the prior art disclosed a particular method for how to prepare a polyethylene terephthalate (\u8220\'3fPET\u8221\'3f) yarn sample. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1337&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1337" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
341 F.3d at 1337, 1340\u8211\'3f42
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Three unpublished methods of PET yarn sample preparation existed in the literature at the time the patent was filed, and a fourth, unpublished method was advanced by the plaintiff\rquote s expert. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 According to the court, \u8220\'3fbecause the sample preparation method is critical to discerning whether a PET yarn has been produced by the claimed process, knowing the proper sample preparation method is necessary to practice the invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1340&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1340" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1adc3d1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1adc3d1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
5. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Analysis
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Whether the 70 mole % limitation is indefinite in light of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote s silence with respect to sample collection and handling is, like the concentration of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, difficult to reliably ascertain. Indeed, the answer to this inquiry appears to lie at the intersection of two related, but somewhat conflicting, notions. First, \u8220\'3f[a] claim is indefinite if its legal scope is not clear enough that a person of ordinary skill in the art could determine whether a particular composition infringes or not.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003867260&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1384&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1384" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Geneva Pharm., Inc. v. GlaxoSmithKline PLC
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 349 F.3d 1373, 1384 (Fed. Cir. 2003)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. That said, \u8220\'3f[t]he test for indefiniteness does not depend on a potential infringer\rquote s ability to ascertain the nature of its own accused product to determine infringement, but instead on whether the claim delineates to a skilled artisan the bounds of the invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2006436300&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1340&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1340" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
SmithKline Beecham Corp. v. Apotex Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 403 F.3d 1331, 1340\u8211\'3f41 (Fed. Cir. 2005)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Because a genuine dispute exists as to whether persons of skill in the art in 2001, after reading the claims, specification, and prosecution history of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, would have understood how to properly collect and handle a sample of cultured microorganisms, the Court cannot grant summary judgment on the issue of definiteness in favor of either party, and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 both Motions with respect to this issue.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The proceedings before the ITC and discovery taken in this action make clear that sample collection and handling are critical to determining whether a given sample accurately reflects the ratio of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 among the entire coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inside the fermentation tank after culturing reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms on an industrial scale. Thus, here, as in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u8220\'3fbecause the sample preparation method is critical to discerning whether [oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
] has been produced by the claimed process, knowing the proper sample preparation method is necessary to practice the invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1340&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1340" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
341 F.3d at 1340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is similar to the patent at issue in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in a second respect: \u8220\'3fthe claims, the written description, and the prosecution history fail to give [the Court], as the interpreter of the claim term, any guidance as to what one of ordinary skill in the art would interpret the claim to require.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 None of these pieces of intrinsic evidence reveal, however, how a sample should be collected or handled prior to testing the sample using the assaying method described between lines 8 and 43 of column 5 and in Example 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
According to Kaneka, that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 does not describe sample collection and handling methods is not fatal to the 70 mole % limitation, as experts on both sides agree that persons of skill in the art knew, even in 2001, that in order to accurately measure the ratio of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in a sample the metabolic activity of the cells in that sample would need to be immediately halted, and that several methods of halting such metabolic activity were known to exist. In particular, Kaneka argues that \u8220\'3f[w]ith respect to the collection and preservation issue (pre-testing), [D]efendants\rquote  expert on invalidity (Dr. Spormann) and Shenzhou\rquote s expert on noninfringement (Dr. Lievense) testified that a person of ordinary skill in the art of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 [P]atent would know the proper methods of sample collection, preservation and testing.\u8221\'3f (Kaneka Mem. 10.) Defendants respond by arguing the cited testimony is taken \u8220\'3fout of context,\u8221\'3f and point to additional testimony indicating that one skilled in the art would need to know the \u8220\'3fvariabilities\u8221\'3f within the microorganism and the conditions 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fthat this compound is subject to\u8221\'3f in order to take an accurate sample. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka Opp\rquote n 8\u8211\'3f9.) Defendants also argue that \u8220\'3fKaneka\rquote s cited testimony does 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
not
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 establish that one skilled in the art would know how to stop metabolic activity of the microorganisms \lquote within a second.\rquote \u8221\'3f (Kaneka Opp\rquote n 9.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_12_63}{\*\bkmkend co_pp_sp_999_12_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*12
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Based on the testimony of both parties\rquote  experts, the Court finds that a person of ordinary skill in the art in 2001 would have understood the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
need to immediately stop
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the metabolic activity of the reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms in order to obtain accurate test results, and also finds that several 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
methods for stopping
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 a microorganism\rquote s metabolic activity were known at that time. Defendants\rquote  invalidity expert, Dr. Alfred Spormann, testified that in 2001, a person of ordinary skill in the art would have understood, even without reading the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, that he or she should \u8220\'3fimmediately\u8221\'3f refrigerate or freeze a sample to obtain the best test results, because \u8220\'3fthe purpose of the refrigeration or the freezing is to stop metabolic activity.\u8221\'3f (Decl. Robert M. Bowick in Supp. Defs.\rquote  Opp\rquote n (\u8220\'3fBowick Opp\rquote n Decl.\u8221\'3f), Ex. 3 at 112:17\u8211\'3f113:20, ECF No. 608\u8211\'3f5.) Similarly, Shenzhou\rquote s noninfringement expert, Dr. Jefferson C. Lievense, testified that freezing would be one of several options to \u8220\'3fimmediate[ly] stop[ ] metabolic activity,\u8221\'3f and that he \u8220\'3fwould look for guidance from the literature in selecting candidate methods to do that.\u8221\'3f (Bowick Opp\rquote n Decl., Ex. 4 at 128:7\u8211\'3f13, ECF No. 608\u8211\'3f6.) Dr. Lievense further testified that \u8220\'3f[i]n the case of freezing, the sample would go directly into a container, which would be placed in liquid nitrogen[,]\u8221\'3f and that \u8220\'3fif the volume is small enough, the time it takes to do that could be on the order of one second.\u8221\'3f (Bowick Opp\rquote n Decl., Ex. 4 at 129:8\u8211\'3f18.) Moreover, Dr. Lievense testified that other methods of immediately stopping metabolic activity would include \u8220\'3fimmediately add[ing] acid\u8221\'3f or \u8220\'3fadd[ing] some sort of solvent or solvent mixture.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
) Finally, Kaneka\rquote s expert, Dr. David H. Sherman, testified that, in his own research, he either freezes or adds solvents to \u8220\'3fessentially immediately\u8221\'3f kill all the cells that have been fermented. (Bowick Opp\rquote n Decl., Ex. 5 at 20:5\u8211\'3f8, 23:10\u8211\'3f15, ECF No. 608\u8211\'3f7.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In light of the above-cited expert testimony, the Court finds there to be no dispute that persons of skill in the art in 2001 both (1) understood the importance of immediately stopping a microorganism\rquote s metabolic activity in order to obtain an accurate sample; and (2) knew that several methods\u8212\'3fincluding freezing, refrigeration, and adding acid or solvents\u8212\'3fexisted to quickly stop a microorganism\rquote s metabolic activity. What 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
is
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 genuinely disputed, however, is whether persons of skill in the art, after reading the claims, specification, and prosecution history of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, would have known, with reasonable certainty, 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
which
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of these methods could be used to collect and store samples in order to practice this limitation. Similarly, there is a genuine dispute regarding the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
duration
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 samples can be stored prior to testing using the assaying method described in the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Takeda Pharmaceutical Co. v. Zydus Pharmaceutical USA, Inc.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, a decision from the Federal Circuit decided prior to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033496707&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Nautilus
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, is instructive. In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Takeda
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the defendant argued the asserted Patent was indefinite because it did not specify the method of measurement that should be used to determine average particle diameter, which the claims required to be less than or equal to 400 micrometers. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1366&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1366" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
743 F.3d 1359, 1366 (Fed. Cir. 2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The defendant insisted several methods existed that could potentially be used to take that measurement, and that the sample could either be infringing or non-infringing depending on the measurement technique used. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Thus, according to the defendant, \u8220\'3fthe skilled artisan has no way to determine whether his or her product infringes the [ ] patent based on the information provided in the specification.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Federal Circuit disagreed, noting that although \u8220\'3fevidence from both parties\rquote  experts [showed] there are several possible ways to measure average particle diameter\u8221\'3f and although the \u8220\'3fexperts agreed that different measurement techniques could indeed produce different results,\u8221\'3f the claims were not indefinite, both because \u8220\'3fthe evidence established that 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
both
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 methods of measurement accurately report average particle diameter\u8221\'3f and because \u8220\'3fthere is no evidence that the differences between these techniques are in fact significant[.]\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1366&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1366" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1366\u8211\'3f67
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (emphasis in original). \u8220\'3f[I]ndeed, there was no evidence in this case that different measurement techniques in fact produced significantly different results for the same sample.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1367&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1367" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1367
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fAny theoretical minor differences between the two techniques are therefore insufficient to render the patent invalid.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1996047376&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1563&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1563" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
PPG Indus., Inc. v. Guardian Indus. Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 75 F.3d 1558, 1563 (Fed. Cir. 1996)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, which found no indefiniteness despite failure to specify which method should be used to measure ultraviolet transmittance because all conventional methods produced \u8220\'3fessentially identical results\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The court in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Takeda
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 distinguished 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, on which Defendants rely, noting that in that case, \u8220\'3f[b]ecause the specification did not discuss which sample preparation method should be used, and the particular method chosen was \lquote critical to discerning whether [an infringing yarn] has been produced by the claimed process,\rquote  we affirmed the Commission\rquote s conclusion that the claims were indefinite.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032754692&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1367&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1367" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1367 n. 4
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1340&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1340" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Honeywell
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 341 F.3d at 1340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
). \u8220\'3fHere, by contrast, no extensive manipulation of the samples is required prior to measurement, and, as discussed above, [the defendant] did not present clear and convincing evidence that the method of measurement is in fact outcome-determinative in the infringement analysis.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003588326&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_13_63}{\*\bkmkend co_pp_sp_999_13_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*13
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The same distinction can be drawn in this case. Although Defendants have presented evidence obtained during the ITC Proceedings showing that refrigerating or freezing samples for different durations can lead to different mole % measurements and ratios, it is far from clear whether these differences are \u8220\'3foutcome-determinative\u8221\'3f when samples are refrigerated or frozen \u8220\'3fimmediately\u8221\'3f and stored for an appropriate period of time, as determined by a person of ordinary skill in the art. It is for the trier of fact to determine what sample collection and handling methods a person of skill in the art would have understood to be appropriate given the claims, specification, and prosecution history of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. Neither party has demonstrated that there are no genuine disputes as to this issue.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In light of the above, the Court finds 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to be distinguishable. In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the claims required that a copolymer have a specific molecular weight \u8220\'3fof about 5 to 9 kiladaltons,\u8221\'3f which could be calculated using one of three known measurement methods. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1338&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1338" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
789 F.3d at 1338
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Unlike the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, none of these measurement methods were disclosed in the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 patent, and thus a person of ordinary skill in the art would not have known which method to use in order to arrive at the claimed molecular weight. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1341, 1344\u8211\'3f45
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. This was critical, because each of the three known measurement methods yielded different results. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1338&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1338" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1338
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. As noted above, however, Defendants have not shown that different sample collection and handling methods understood by persons of skill in the art to be appropriate would yield different mole % ratios. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036481053&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Teva
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 is therefore inapposite.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, which was an appeal from a bench trial, the asserted claims required a \u8220\'3fslope of strain hardening coefficient greater or equal to 1.3,\u8221\'3f which could be calculated using one of four measurement methods. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_622&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_622" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
803 F.3d at 622, 624\u8211\'3f27
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 patents, unlike the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, failed to disclose any of these measurement methods, and the Federal Circuit noted that \u8220\'3f[t]here is no question that each of these four methods may produce different results.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_633&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_633" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 633
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Indeed, the Federal Circuit noted that \u8220\'3f[b]ecause the methods do not always produce the same results, the method chosen for calculating the slope of strain hardening could affect whether or not a given product infringes the claims.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_634&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_634" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 634
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Because the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 patents failed to disclose which method of measurement should be used, the Federal Circuit held that a person of ordinary skill in the art would not know which method to use in order to arrive at the claimed coefficient. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_635&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_635" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 635
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Here again, by contrast, Defendants have not shown that different sample collection and handling methods understood by persons of skill in the art to be appropriate would yield different mole % ratios, and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036969807&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Dow
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 is therefore distinguishable.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court also rejects Defendants\rquote  argument that the 70 mole % limitation must be indefinite because (1) Kaneka\rquote s own expert, Dr. Sherman, found that the testing of the mole % ratio by a co-inventor of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 was not reliable in light of a lack of description regarding how the samples were handled between harvesting and testing; or (2) Kaneka failed to follow its own \u8220\'3fmobile laboratory\u8221\'3f protocol upon remand from the Federal Circuit. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Cf
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Defs.\rquote  Mem. 10\u8211\'3f14.) First, that a particular test conducted by one of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote s co-inventors either was unsuccessful or used unclear or improper methods does not demonstrate that persons of skill in the art were unaware of how to properly collect and handle cell samples, and Defendants cite no authority indicating otherwise. Second, the fact that a party has developed a particular protocol for proving whether a defendant has committed infringement does not, by itself, indicate that persons of skill in the art were previously incapable of understanding how to accurately test a sample. Such an inference is particularly difficult to draw where, as here, it appears that the need to create such a \u8220\'3fmobile laboratory\u8221\'3f arose because of the remoteness of XKGC and Shenzhou\rquote s facilities and because these defendants did not permit Kaneka to test samples at their facilities. To the extent Defendants challenge the accuracy and reliability of the \u8220\'3fmobile laboratory\u8221\'3f method itself, such an argument concerns infringement, rather than indefiniteness. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Cf
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. Defs.\rquote  Mem. 13\u8211\'3f14.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_14_63}{\*\bkmkend co_pp_sp_999_14_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*14
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court also finds occasion to recite the bedrock principle of patent law that a claim is not indefinite merely because it is difficult to determine whether one\rquote s own product infringes, for this difficulty may lie in the inadequacy of testing procedures rather than imprecision in the claim language. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024157544&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1346&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1346" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Spansion, Inc. v. Int\rquote l Trade Comm\rquote n
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 629 F.3d 1331, 1346 (Fed. Cir. 2010)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fThe difficulty or complexity of the infringement analysis does not necessarily speak to whether a claim is definite or not.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
); 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2006436300&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1340&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1340" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
SmithKline Beecham Corp. v. Apotex Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 403 F.3d 1331, 1340\u8211\'3f41 (Fed. Cir. 2005)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3fThe test for indefiniteness does not depend on a potential infringer\rquote s ability to ascertain the nature of its own accused product to determine infringement, but instead on whether the claim delineates to a skilled artisan the bounds of the invention.\u8221\'3f). For example, in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2007423393&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Invitrogen Corp. v. Biocrest Manufacturing, L.P.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit affirmed the district court\rquote s summary judgment finding that a claim reciting the term \u8220\'3fimproved competence\u8221\'3f was not indefinite, rejecting the accused infringer\rquote s argument that because testing was required to know whether a product infringed, the claim should be considered to be indefinite. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2007423393&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1384&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1384" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
424 F.3d 1374, 1384 (Fed. Cir. 2005)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. The Federal Circuit wrote:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Stratagene further argues that it would have had to practice the claimed process in order to determine if it was infringing, even though \u8220\'3f[t]he primary purpose of the definiteness requirement is to ensure that the claims are written in such a way ... that interested members of the public ... can determine whether or not they infringe.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003071344&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1340&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1340" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Oakley, Inc. v. Sunglass Hut Int\rquote l
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 316 F.3d 1331, 1340 (Fed. Cir. 2003)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Indeed, the lower court had to have separate side-by-side tests done to determine whether Stratagene infringed, and other testimony indicates that tests were necessary to determine infringement. However, Oakley goes on to explain that \u8220\'3fa patentee 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
need not define his invention with mathematical precision
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in order to comply with the definiteness requirement.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2003071344&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1341
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Stratagene is really talking about the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
difficulty of avoiding infringement, not indefiniteness
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of the claim. \u8220\'3fThe test for indefiniteness does not depend on a potential infringer\rquote s ability to ascertain the nature of its own accused product to determine infringement, but instead on whether the claim delineates to a skilled artisan the bounds of the invention.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2006436300&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
SmithKline Beecham Corp. v. Apotex Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 403 F.3d 1331, 1341 (Fed. Cir. 2005)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. This court\rquote s and the district court\rquote s constructions of the claim showed that it contained no material ambiguities, and therefore was not invalid for indefiniteness. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002682231&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_780&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_780" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
All Dental Prodx, LLC v. Advantage Dental Prods., Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 309 F.3d 774, 780 (Fed. Cir. 2002)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2007423393&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1384&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1384" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Invitrogen
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 424 F.3d at 1384
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (emphasis added). Thus, to the extent the parties\rquote  definiteness arguments turn on the tests performed on samples taken from Manufacturing Defendants\rquote  fermentation tanks, the Court cautions that methods used to determine whether Manufacturing Defendants\rquote  processes practice the 70 mole % limitation are not necessarily indicative of whether a person of skill in the art in 2001 would have understood the scope of this limitation.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
For the foregoing reasons, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 both Kaneka\rquote s and Defendants\u8217\'3f Motions for Summary Judgment on the issue of whether the asserted claims are indefinite under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 \u182\'3f 2.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1c73f41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1c73f41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1c73f41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1c73f41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
B. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
Whether the Asserted Claims Are Patent\u8211\'3fEligible Under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
\sb200 
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants next contend that the asserted claims are invalid under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for claiming a natural phenomenon combined with conventional steps. (Defs.\rquote  Mem. 17\u8211\'3f24.) In particular, Defendants argue that because microorganisms are able to produce microbial cells containing \u8220\'3fnot less than 70 mole %\u8221\'3f reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and because the 70 mole % limitation is merely identified, the asserted claims are directed to a patent-ineligible natural phenomenon very similar to that at issue in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo Collaborative Services v. Prometheus Laboratories, Inc.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defs.\rquote  Mem. 17\u8211\'3f18.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_15_63}{\*\bkmkend co_pp_sp_999_15_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*15
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka responds that the asserted claims are patent-eligible because the inventors did not stop at identifying certain microorganisms with the ability to produce reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at ratios greater than 70 mole % under specific culturing conditions, but instead used this knowledge to create a new and useful method of producing oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an industrial scale. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka Mem. 12\u8211\'3f20.) Kaneka points out that PTO examiners noted that a process of culturing microorganisms to produce greater than 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and then actively oxidizing the resulting culture was neither routine nor conventional, and that the patented process yields the specific benefit of creating oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 with greater purity without (Z)\u8211\'3fisomers and (all-E) isomers. (Kaneka Mem. 19\u8211\'3f20.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
For the reasons that follow, the Court agrees with Kaneka that the asserted claims are patent-eligible under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Court therefore 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Motion for Summary Judgment on this issue, and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\u8217\'3f Motion.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1ca9aa1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1ca9aa1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Step 1: Whether the Claims Are \u8220\'3fDirected to\u8221\'3f a Natural Phenomenon
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fWe begin with step one: whether the claims here are \lquote directed to\rquote  a patent-ineligible concept.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d at 1047
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. The Court concludes that they are not.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The asserted claims recite a \u8220\'3f
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
process for producing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
industrial scale
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
oxidized
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 25, ll. 32\u8211\'3f33; col. 26, ll. 13\u8211\'3f14 [emphasis added].) The claimed processes require an artisan to carry out several steps to achieve the desired production, including (1) culturing reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms in a specific culture medium; (2) optionally disrupting the microorganisms; (3) actively oxidizing the reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; and (4) extracting the CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 with an organic solvent in a sealed tank. The end result of this process, according to the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, is oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of a high purity produced \u8220\'3fsafely and efficiently on the industrial scale.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 3, ll. 33\u8211\'3f
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; col. 4, ll. 28\u8211\'3f36.) Thus, according to the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the claimed process \u8220\'3fachieved a notable advance over prior art techniques\u8221\'3f for creating high-purity oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an industrial scale. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d at 1047
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Notwithstanding that the plain claim language refers to producing oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an industrial scale, Defendants contend that the asserted claims are \u8220\'3fdirected to\u8221\'3f the natural phenomenon that certain microorganisms have the natural ability to produce at least 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 under standardized culturing conditions. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Mem. 18 [citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 col. 4, ll. 61\u8211\'3f65].) According to Defendants, because the 70 mole % limitation discussed at length in Section III(A), 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, is \u8220\'3fmerely identified,\u8221\'3f the asserted claims are directed to the natural ability of these microorganisms to produce at least 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. (Defs.\rquote  Mem. 18\u8211\'3f20.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The parties correctly note that 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is particularly instructive. In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Federal Circuit found claims reciting a \u8220\'3fmethod of producing a desired preparation of multi-cryopreserved hepatocytes,\u8221\'3f coupled with several concrete steps,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00032044683407_ID0E2KCI_63}{\*\bkmkend co_fnRef_B00032044683407_ID0E2KCI_63}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00032044683407_63" }{\fldrslt 
{\super \b0 \cf20 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
3
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to be patent-eligible because the claims were not \u8220\'3fdirected to\u8221\'3f the natural phenomenon that hepatocytes are capable of surviving multiple freeze-thaw cycles. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
827 F.3d at 1047\u8211\'3f50
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Federal Circuit distinguished these claims from those found to be patent-ineligible in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Association for Molecular Pathology v. Myriad Genetics, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), 569 U.S. 576, 133 S.Ct. 2107, 186 L.Ed.2d 124 (2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Technologies, Ltd. v. Merial L.L.C.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Technologies
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), 818 F.3d 1369 (Fed. Cir. 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa Diagnostics, Inc. v. Sequenom, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), 788 F.3d 1371 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
BRCA1\u8211\'3f& BRCA2\u8211\'3fBased Hereditary Cancer Test Patent Litigation
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re BRCA
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f), 774 F.3d 755 (Fed. Cir. 2014)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 because \u8220\'3fthe end result of the [asserted] claims is 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
not simply an observation or detection of the ability
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of hepatocytes to survive multiple freeze-thaw cycles,\u8221\'3f but were instead \u8220\'3fdirected to a 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
new and useful method of preserving
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 hepatocyte cells.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1048&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1048" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1048
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 (emphasis added). According to the court:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_16_63}{\*\bkmkend co_pp_sp_999_16_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*16
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Through the recited steps, the patented invention achieves a better way of preserving hepatocytes. The \lquote 929 patent claims are like thousands of others that recite processes to achieve a desired outcome, e.g., methods of producing things, or methods of treating disease. That one way of describing the process is to describe the natural ability of the subject matter to 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
undergo
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the process does not make the claim \u8220\'3fdirected to\u8221\'3f that natural ability. If that were so, we would find patent-ineligible methods of, say, producing a new compound (as directed to the individual components\rquote  ability to combine to form the new compound), treating 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancer
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 with chemotherapy (as directed to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
cancer
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 cells\rquote  inability to survive chemotherapy), or treating headaches with 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=I3af17fb7475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
aspirin
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (as directed to the human body\rquote s natural response to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=gdrug&entityId=I3af17fb7475111db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
aspirin
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1048&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1048" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1048\u8211\'3f49
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (emphasis in original). The Federal Circuit went on to distinguish the claims before it from those at issue in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Funk Brothers. Co. v.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Kalo Inoculant Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 333 U.S. 127, 68 S.Ct. 440, 92 L.Ed. 588 (1948)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, by noting that \u8220\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Funk Bros.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 involved product claims, and the court explicitly noted that it was not \lquote presented [with] the question whether the methods of selecting and testing the non-inhibitive strains are patentable.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1049&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1049" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1049
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_130&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_130" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Funk Bros.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 333 U.S. at 130, 68 S.Ct. 440
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Thus, \u8220\'3f[h]ere, regardless of whether the individual hepatocytes in the pool of multi-cryopreserved hepatocytes have the same effect they always had or perform in their natural way, the claims are directed to a new and useful process of creating that pool, not to the pool itself.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1948116775&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Federal Circuit distinguished the claims before it from those at issue in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on similar grounds. First, in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Myriad
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, the Supreme Court stated that
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
It is important to note what is 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
not
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 implicated by this decision. First, there are no method claims before this Court. Had Myriad created an innovative method of manipulating genes while searching for the BRCA1 and BRCA2 genes, it could have possibly sought a method patent. But the processes used by Myriad to isolate DNA were well understood ... and are not at issue in this case.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2119&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2119" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
569 U.S. 576, 133 S.Ct. 2107, 2119\u8211\'3f20, 186 L.Ed.2d 124 (2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (emphasis in original). In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, however, \u8220\'3fthe inventors developed an innovative method of manipulating hepatocytes, a particular kind of liver cell which, prior to this invention, had been very difficult to preserve for future use.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1049&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1049" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
827 F.3d at 1049
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Second, \u8220\'3f[a]lthough the claims in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 were also written as process claims, the court concluded that they were \lquote directed to\rquote  the patent-ineligible cffDNA itself.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1376&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1376" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
788 F.3d at 1376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants pay mere lip service to these principles. Here, as in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the claims are \u8220\'3fdirected to\u8221\'3f a superior method of producing a certain end product\u8212\'3fin this case, efficiently creating oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an industrial scale\u8212\'3frather than to the inherent properties of certain biological materials. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
That the asserted claims rely on the ability of certain microorganisms to produce reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio greater than 70 mole % among the entire coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 under standard culturing conditions does not indicate the claims are \u8220\'3fdirected to\u8221\'3f this phenomenon. \u8220\'3fRather, the claims of the \lquote [340] patent are directed to a new and useful [industrial process] for [manufacturing oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
].\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1048&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1048" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
CellzDirect
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 827 F.3d at 1048
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Indeed, Kaneka has identified language in the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 indicating the claimed invention provides several advances over prior art techniques for creating oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 on an industrial scale:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_17_63}{\*\bkmkend co_pp_sp_999_17_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*17
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 According to the processes of the present invention, reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 can be produced cheaply on the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
industrial scale
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 by considerably simple steps comprising culturing microorganisms and recovering reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In addition, oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 can also be 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
produced by simple processes
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Moreover, these coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 produced by microorganisms 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
basically do not contain (Z)-isomers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 thereof, and (all-E) isomers thereof can be obtained, which are same as those contained in meat, fish, etc.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 4, ll. 28\u8211\'3f36 [emphasis added].)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In light of the above, the asserted claims are readily distinguishable from those at issue in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Technologies
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re BRCA
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The claims in the first two cases recited methods for detecting coding regions of DNA and cffDNA, respectively, based on these regions\rquote  relationships to non-coding regions. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038639328&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1369&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1369" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Genetic Techs.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 818 F.3d at 1369, 1373\u8211\'3f74
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1373&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1373" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1373\u8211\'3f74
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
cert. denied
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2038509343&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
No. 15-1102, \u8211\'3f\u8211\'3f\u8211\'3f U.S. \u8211\'3f\u8211\'3f\u8211\'3f\u8211\'3f, 136 S.Ct. 2511, 195 L.Ed.2d 841 (June 27, 2016)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The existence and location of DNA or cffDNA is a natural phenomenon, and identifying the presence of certain regions based on the location of non-coding regions is tantamount to claiming the natural phenomenon itself. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036438466&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1376&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1376" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Ariosa
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 788 F.3d at 1376
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (holding that, because the method \u8220\'3fstarts with cffDNA taken from a sample of maternal plasma or serum\u8212\'3fa naturally occurring non-cellular DNA that circulates freely in the blood stream of a pregnant woman\u8221\'3f and \u8220\'3fends with paternally inherited cffDNA, which is also a natural phenomenon [the] method therefore begins and ends with a natural phenomenon\u8221\'3f and \u8220\'3fthe claims are directed to matter that is naturally occurring\u8221\'3f). Here, by contrast, the claims call for culturing certain microorganisms on an industrial level in order to obtain reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 above a certain ratio, disrupting the microbial cells, and then oxidizing the reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and extracting the resulting oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in a sealed tank. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.) The cases are not analogous.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re BRCA
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is similarly inapposite. In that case, the claims recited methods for screening human germline for an altered BRCA1 gene by comparing the target 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_761&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_761" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DNA sequence with a wild-type sequence. 774 F.3d at 761\u8211\'3f62
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Comparing two sequences in order to detect alterations, however, is a patent-ineligible \u8220\'3fabstract mental process.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_763&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_763" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 763
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
. Thus, although the claims in this case also employed method steps, the end result of the process was a patent-ineligible concept.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants decry the lack of a yield requirement in the oxidation step, arguing that without such a limitation, the oxidizing, extracting, and optional disrupting steps \u8220\'3fsimply are not required to actually make a particular amount of oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 from the starting ratio of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (Kaneka Opp\rquote n 16.) Defendants further argue that \u8220\'3f[t]he combination of steps cannot help given the Federal Circuit\rquote s construction\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 because \u8220\'3f[s]ince the 70 mole % reduced ratio need not be maintained and the yield of oxidized [CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
] is not limited, the mole % reduced can be either above or below 70 mole % before or after extraction and before or after oxidation.\u8221\'3f (Kaneka Opp\rquote n 17.) Defendants cite no facts or legal authority in support of either argument. Moreover, the intrinsic record suggests there are benefits associated with using reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 created by microorganisms at a ratio of at least 70% to form oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an industrial scale, including the elimination of certain problematic isomers and a higher yield of oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in a simple, safe, and cost-effective manner. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 col. 2, ll. 28\u8211\'3f37; col. 3., ll. 33\u8211\'3f46; col. 4, ll. 28\u8211\'3f36.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_18_63}{\*\bkmkend co_pp_sp_999_18_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*18
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 For the foregoing reasons, the Court concludes that the asserted claims are not \u8220\'3fdirected to\u8221\'3f the natural phenomenon that certain microorganisms have the natural ability to produce at least 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 under standardized culturing conditions, and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Kaneka\rquote s Motion for Summary Judgment on this issue.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1da7921053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1da7921053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Step 2: Whether the Asserted Claims Contain an \u8220\'3fInventive Concept\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Even if the Court were to conclude that the asserted claims are \u8220\'3fdirected to\u8221\'3f the natural phenomenon that certain microorganisms have the natural ability to produce at least 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 under standardized culturing conditions, it would nevertheless conclude that the remaining elements, viewed in isolation and in combination with the other non-patent-ineligible elements, are sufficient to \u8220\'3f \lquote transform the nature of the claim into a patent-eligible application.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mayo
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 132 S.Ct. at 1297
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Step two of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Section
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 inquiry requires searching for an \u8220\'3finventive concept to take the claim into the realm of patent-eligibility.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
In re BRCA
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2035063513&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_764&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_764" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
774 F.3d at 764
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Such an \u8220\'3finventive concept\u8221\'3f is present here. As a starting point, as discussed above, the asserted claims require much more than identifying microorganisms capable of culturing reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of at least 70 mole % in a particular medium. In addition to this step, an artisan must actively oxidize the reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and extract the oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 using an organic solvent in a sealed tank, and may optionally disrupt the microbial cells to obtain the reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.) Although each of these steps might have been known to skilled artisans, Kaneka points to evidence indicating a process of culturing microorganisms to produce greater than 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and then actively oxidizing the CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 was far from \u8220\'3froutine\u8221\'3f or \u8220\'3fconventional.\u8221\'3f Indeed, the PTO clarified during reexamination of the claims of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 that:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
While the culturing conditions and steps for isolating coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 from 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=mproc&entityId=I710dd681995711de9b8c850332338889&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
microbial culture
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 may have been conventional and well-known in the art, the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
choice of specific microorganisms
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 having the claimed properties of reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
was not
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Particularly, as the claims as a whole are drawn to include steps for the production of oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as a final product, there was 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
no motivation to choose
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 for the initial steps in the culturing processes microorganisms that naturally contain \u8220\'3freduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of not less than 70 mole % among the entire coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(Bowick Opp\rquote n Decl., Ex. 9 [emphasis added].) Thus, according to the examiner, it took some inventiveness on the part of the applicants to use reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of at least 70 mole % as a starting product for the industrial production of oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Defendants have not pointed to any evidence indicating that creating oxidized CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 on an industrial scale by starting with reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of a certain ratio was not \u8220\'3finventive.\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Thus, even if the asserted claims were \u8220\'3fdirected to\u8221\'3f the natural phenomenon that certain microorganisms have the natural ability to produce at least 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 under standardized culturing conditions, the Court would nevertheless conclude that the claims contain an inventive concept that brings the claims into the realm of patent-eligibility. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Alice
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 134 S.Ct. at 2355
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1de97d1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1de97d1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1de97d1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1de97d1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
C. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
Whether a Genuine Dispute Exists Regarding Anticipation by 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb0 
 and the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f
}
}
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb400 
2002 Process
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
The Parties\rquote  Arguments
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_19_63}{\*\bkmkend co_pp_sp_999_19_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*19
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka next seeks summary judgment that the asserted claims are not anticipated under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. Section 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. According to Kaneka, although Defendants asserted Kaneka\rquote s 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as the sole anticipatory reference in their Final Amended Invalidity Contentions, they nevertheless added a 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
second
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 anticipatory reference\u8212\'3f
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1962033736&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=I20754e30721411d7a5a58ae19b0bc350&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
U.S. Patent No. 3,066,080
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 to Folkers et al. (\u8220\'3f
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f)\u8212\'3fin the expert report and testimony of Dr. Spormann. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka Mem. 3.) Kaneka first argues that any reliance on 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as an anticipatory reference is improper. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka Mem. 3.) Notwithstanding whether 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 is a proper reference, Kaneka further contends that Dr. Spormann has admitted that neither reference contains an \u8220\'3factive oxidation step.\u8221\'3f (Kaneka Mem. 4\u8211\'3f7.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants respond by arguing that they, through the opinions of Dr. Spormann and through other materials, have provided 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
prima facie
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 evidence that both 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 satisfy the \u8220\'3factive\u8221\'3f oxidation limitation as construed by the Federal Circuit. (Kaneka Opp\rquote n 2.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1e093a1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1e093a1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Analysis
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3fWhether a patent is anticipated under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=SP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_a83b000018c76" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
section 102(b)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is a question of fact.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002666702&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1315&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1315" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Schumer v. Lab. Computer Sys., Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 308 F.3d 1304, 1315 (Fed. Cir. 2002)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2000638696&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_20&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_20" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Apple Computer, Inc. v. Articulate Sys., Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 234 F.3d 14, 20 (Fed. Cir. 2000)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). \u8220\'3fOn summary judgment, all justifiable inferences are made in favor of the nonmovant, here [Defendants].\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2000638696&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (citing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_255&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_255" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Liberty Lobby
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 477 U.S. at 255, 106 S.Ct. 2505
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Each of the asserted claims requires \u8220\'3foxidizing\u8221\'3f reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3fto oxidized coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,\u8221\'3f although the claims differ with respect to whether such oxidation begins before or after the \u8220\'3fextraction\u8221\'3f step. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.) In its Opinion, the Federal Circuit concluded that although \u8220\'3foxidation requires an active step,\u8221\'3f it \u8220\'3fdoes not require the use of an oxidizing agent.\u8221\'3f (Opinion 1305\u8211\'3f06.) The Federal Circuit also required that \u8220\'3fat least some action resulting in oxidation must be applied to the disruption step in claim 22, and the product of the extraction step in claim 33.\u8221\'3f (Opinion 1306.) In addition, the Federal Circuit \u8220\'3fdisagree[d] that the claimed order excludes passive oxidation during other process steps\u8221\'3f and further \u8220\'3fdisagree[d] ... that the claimed order requires that each step occur independently or separately.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1986132674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
) The Federal Circuit summarized its construction as follows:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
[T]he oxidation step requires some action that results in oxidation but does not require oxidation of \u8220\'3fall or substantially all\u8221\'3f of the coenzyme Q10. Because the oxidation step indicates that oxidation is carried out on the product from the previous disruption step in claim 22, some action resulting in oxidation must occur after some product from the disruption step forms and before the extraction step in claim 22 begins. Similarly, some action resulting in oxidation must occur after at least some reduced coenzyme Q10 has been extracted in claim 33. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
Because the claims read on a continuous process, a process step does not need to be complete before another step begins. Thus, it is not required that any one step be carried out separately or independently of any other step.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(Opinion 1307.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
According to Kaneka\rquote s Final Infringement Contentions, two actions on the part of Defendants constitute the \u8220\'3factive step\u8221\'3f required for oxidation. First, there is \u8220\'3fwashing\u8221\'3f and \u8220\'3fdrying\u8221\'3f the biomass of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s FICs for Shenzhou at 21\u8211\'3f22, ECF No. 518\u8211\'3f1; Kaneka\rquote s FICs for XKGC at 20\u8211\'3f22, ECF No. 518\u8211\'3f2.) Second, there is \u8220\'3fair drying.\u8221\'3f (Kaneka\rquote s FICs for Shenzhou at 24\u8211\'3f26; Kaneka\rquote s FICs for XKGC at 22\u8211\'3f26.) Defendants nevertheless contend that Kaneka has identified a third alleged \u8220\'3factive\u8221\'3f oxidation step\u8212\'3facid\u8211\'3fheat treatment\u8212\'3falthough the Court cannot find support for this argument. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka Opp\rquote n 2\u8211\'3f3.) Defendants and their expert, Dr. Spormann, \u8220\'3fdispute that any of these three steps satisfies the \lquote active\rquote  oxidation limitation of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,\u8221\'3f but argue that \u8220\'3fto the extent Kaneka\rquote s contentions are adopted, 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and [the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
] meet the \lquote active\rquote  oxidation limitation of Claims 22 and 33 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.\u8221\'3f (Kaneka Opp\rquote n 3.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_20_63}{\*\bkmkend co_pp_sp_999_20_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*20
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 As a threshold matter, the Court agrees with Kaneka that Defendants should be precluded from relying on 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as an anticipatory reference, as this reference was not properly included in Defendants\rquote  Final Invalidity Contentions. Kaneka submits that \u8220\'3fDefendants\rquote  Final Amended Invalidity Contentions (10\u8211\'3f03\u8211\'3f2016) only asserted Kaneka\rquote s pre\u8211\'3f2002 Process as an anticipatory reference under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
[,]\u8221\'3f providing a copy of these contentions as evidence. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Pl. Kaneka Corp.\rquote s Statement of Uncontroverted Facts and Conclusions of Law in Supp. Kaneka Mem. (\u8220\'3fKaneka\rquote s Facts\u8221\'3f) \u182\'3f 10, ECF No. 556\u8211\'3f2.) In response, Defendants do not dispute that 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 was not included as an anticipatory reference in their Final Amended Invalidity Contentions, but instead submit that they stated in these contentions that they \u8220\'3fwill revise their contentions concerning the invalidity of the claims of the Asserted Patent as appropriate depending upon ... positions that Kaneka or its expert witness(es) may take concerning claim interpretation, infringement, and/or invalidity issues.\u8221\'3f (Defs.\rquote  Response \u182\'3f 10.) The Court made clear in its September 13, 2016 Order Granting in Part and Denying in Part Plaintiff Kaneka Corporation\rquote s Motion for Leave to Amend Its Final Infringement Contentions that it would hold both sides to the theories provided in their final infringement and invalidity contentions. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order Granting in Part & Den. in Part Kaneka\rquote s Mot. For Leave to Amend Its FICs, ECF No. 513.) Defendants have not demonstrated \u8220\'3fgood cause\u8221\'3f for belatedly shoehorning 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 into Dr. Spormann\rquote s expert report. As such, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS IN PART
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Motion and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
PRECLUDES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendants from arguing that 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 anticipates any of the asserted claims under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. Section 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2032420481&pubNum=0000999&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
MyMedicalRecords, Inc. v. Walgreen Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, No. 2:13-cv-00631-ODW( ), 2013 WL 6834639 (C.D. Cal. Dec. 23, 2013)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 (striking supplemental invalidity contentions that were both untimely and improperly amended without a court order and denying leave to amend for lack of good cause).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Turning to the second anticipatory reference, the Court has reviewed Dr. Spormann\rquote s expert report on invalidity (\u8220\'3fSpormann Invalidity Report\u8221\'3f) and his December 2, 2016 deposition transcript, and finds there to be a genuine dispute as to whether Kaneka\rquote s 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 disclose an \u8220\'3factive oxidation\u8221\'3f step. Because the determination whether a particular process meets the \u8220\'3factive oxidation\u8221\'3f limitation is a question of fact, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Motion for Summary Judgment on the issue of whether the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 anticipates any of the asserted claims.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
First, the portions of Dr. Spormann\rquote s deposition testimony Kaneka cites in its moving papers do little more than reveal the tension between Dr. Spormann\rquote s views regarding whether the three types of \u8220\'3factive\u8221\'3f oxidation (apparently) advanced by Kaneka meet the Federal Circuit\rquote s construction of the oxidizing limitation and his interpretation of Kaneka\rquote s three infringement theories. In the Spormann Invalidity Report, Dr. Spormann opines that, \u8220\'3fapplying the logic of Kaneka\rquote s tutorial and infringement contentions,\u8221\'3f (1) Kaneka\rquote s [REDACTED] used in the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 meets the oxidizing limitation found in claim 22; and (2) Kaneka\rquote s [REDACTED] used in the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 meets the oxidizing limitation found in claim 33. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Decl. Lei Mei in Supp. Kaneka Opp\rquote n (\u8220\'3fMei Opp\rquote n Decl.\u8221\'3f), Ex. B at \u182\'3f\u182\'3f 123\u8211\'3f24, ECF No. 600\u8211\'3f3.) Making all justifiable inferences in Defendants\rquote  favor, as the Court must when ruling on a motion for summary judgment, the Court finds there to be a genuine dispute as to whether the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 anticipates the asserted claims.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00042044683407_ID0EDBAK_63}{\*\bkmkend co_fnRef_B00042044683407_ID0EDBAK_63}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00042044683407_63" }{\fldrslt 
{\super \b0 \cf20 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
4
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court finds a second basis for denying Kaneka summary judgment on the basis of anticipation: the possibility that because the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 calls for the [REDACTED], it anticipates claim 33. Kaneka argues that because Dr. Spormann admitted during his deposition that the [REDACTED] in Kaneka\rquote s 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 occurred [REDACTED] the addition of this compound cannot meet the \u8220\'3factive oxidation\u8221\'3f limitation. (Kaneka Mem. 7.) Defendants point to evidence indicating that during the \u8220\'3ffirst extraction\u8221\'3f as part of Kaneka\rquote s 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Kaneka [REDACTED] (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Mei Opp\rquote n Decl., Ex. F at KAN790ITC003770974.) In light of this evidence, the Court cannot say whether some amount of \u8220\'3fextraction\u8221\'3f occurs prior to the [REDACTED] such that the addition of this compound meets the \u8220\'3foxidizing\u8221\'3f limitation. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order 13 [holding that \u8220\'3fsome action resulting in oxidation must occur after at least some reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 has been extracted in claim 33\u8221\'3f].) The Court must therefore 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENY
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\u8217\'3f Motion for Summary Judgment on this issue.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1e96d41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1e96d41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1e96d41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1e96d41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
D. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
Whether Manufacturing Defendants\rquote  Processes Infringe the Asserted Claims
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_21_63}{\*\bkmkend co_pp_sp_999_21_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*21
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The final issue the Court must determine is whether a genuine dispute exists as to whether Manufacturing Defendants\rquote  processes infringe one or more of the asserted claims. Defendants raise the following four noninfringement arguments. First, they argue that XKGC does not culture \u8220\'3freduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms,\u8221\'3f but instead cultures photosynthetic bacteria. (Defs.\rquote  Mem. 25\u8211\'3f29.) Second, they contend that Kaneka has no evidence that XKGC\rquote s processes meet the 70 mole % limitation, either literally or under the doctrine of equivalents. (Defs.\rquote  Mem. 29\u8211\'3f31.) Third, they argue that XKGC does not use a \u8220\'3fsealed tank,\u8221\'3f and that Kaneka essentially conceded that it would be impossible to have a \u8220\'3fsealed tank\u8221\'3f in an industrial scale process as the term was construed by the Federal Circuit. (Defs.\rquote  Mem. 31\u8211\'3f34.) Finally, Defendants submit the processes do not infringe claim 22, at the very least, because neither process performs an \u8220\'3foxidizing\u8221\'3f step. (Defs.\rquote  Mem. 34\u8211\'3f
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka responds to each of these arguments as follows. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
First, Kaneka argues that Defendants should be judicially estopped from attempting to narrow the construction of the culturing step, and further argues that Judge Pfaelzer previously rejected Defendants\rquote  effort to import an \u8220\'3fend of fermentation\u8221\'3f limitation into the \u8220\'3fculturing\u8221\'3f step. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Mem. of Ps & As in Opp\rquote n Defs.\rquote  Mot. (\u8220\'3fDefs.\rquote  Opp\rquote n\u8221\'3f) 19\u8211\'3f24, ECF No. 608.) Kaneka also argues that the term \u8220\'3fmicroorganisms\u8221\'3f includes photosynthetic bacteria. (Defs.\rquote  Opp\rquote n 24\u8211\'3f31.) Kaneka next points to evidence indicating XKGC\rquote s old and new manufacturing processes practice the 70 mole % limitation. (Defs.\rquote  Opp\rquote n 31\u8211\'3f34.) Finally, Kaneka argues that because Defendants have pointed to no \u8220\'3fevidence\u8221\'3f that XKGC does not extract in \u8220\'3fsealed tanks,\u8221\'3f Kaneka\rquote s affirmative evidence is sufficient to defeat summary judgment on this issue, both with respect to literal infringement and infringement under the DOE. (Defs.\rquote  Opp\rquote n 34\u8211\'3f38.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1eb6911053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1eb6911053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Issues Related to the \u8220\'3fCulturing\u8221\'3f Step
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
Defendants begin their noninfringement arguments by raising several issues concerning the \u8220\'3fculturing\u8221\'3f step recited in each of the asserted claims. The Court addresses each of these arguments in turn.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1ebb731053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1ebb731053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
a. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether the \u8220\'3fCulturing\u8221\'3f Step Requires \u8220\'3fPre\u8211\'3fScreening\u8221\'3f Testing
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
First, Defendants argue Kaneka has \u8220\'3fno proof\u8221\'3f that XKGC cultures \u8220\'3freduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms\u8221\'3f because Kaneka never cultured their bacteria pursuant to the assay described between column 4, line 51 and column 5, line 43 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8217\'3f340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Defs.\rquote  Mem. 25.) Defendants contend that, as a corollary to the above, since there is a separate requirement that the microbial cells contain at least 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, limiting the scope of this phrase \u8220\'3fis needed to eliminate redundancy and give meaning to the phrase.\u8221\'3f (Defs.\rquote  Mem. 25.) Defendants then point out that they do not use any of the 63 strains of bacteria listed in Tables 1\u8211\'3f3 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8217\'3f340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (Defs.\rquote  Mem. 26.) Finally, Defendants note that Kaneka\rquote s own testing of certain strains of bacteria demonstrates these bacteria produced microbial cells with less than 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 when cultured and measured pursuant to the assay described in the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, and that Shenzhou\rquote s own tests of its strain of one of these bacteria yielded the same result. (Defs.\rquote  Mem. 26\u8211\'3f27.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka does not dispute that it never cultured Defendants\rquote  photosynthetic bacteria pursuant to the assay described between column 4, line 51 and column 5, line 43 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Response to Defs.\rquote  Statement of Uncontroverted Facts and Conclusions of Law (\u8220\'3fKaneka Resp.\u8221\'3f) \u182\'3f 47, ECF No. 608\u8211\'3f1.) Instead, Kaneka argues that the claims do not require Defendants to evaluate their bacteria according to this test-tube assay in order to practice the \u8220\'3fculturing\u8221\'3f step. Moreover, Kaneka notes that until the deadline for disclosure of Defendants\rquote  expert reports on noninfringement, they had never advocated limiting this claim element to the laboratory-scale culturing experiment described between column 4, line 51 and column 5, line 43 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defs.\rquote  Opp\rquote n 20.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_22_63}{\*\bkmkend co_pp_sp_999_22_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*22
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court agrees with Kaneka that taking this laboratory-scale measurement is not required under the Court\rquote s construction of the \u8220\'3fculturing\u8221\'3f step, and further agrees that Defendants are judicially estopped from advancing such an argument. The Court has reviewed Defendants\rquote  
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 briefs, and notes that Defendants themselves argued to Judge Pfaelzer that \u8220\'3fthe relevant sampling point to determine whether the 70% limitation is met is at the end of fermentation,\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 which is \u8220\'3fconsistent with a natural reading of each independent claim, which requires 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
culturing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 microorganisms 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
to obtain
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 microbial cells containing 70 mole % reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (Defs.\rquote  Responsive Claim Construction Br. 22 [emphasis in original], ECF No. 146.) Judge Pfaelzer adopted Defendants\rquote  proposed construction, requiring that the assay described at column 5 between lines 8 and 43, rather than the one described between column 4, line 51 and column 5, line 43, be used to determine the ratio of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Claim Construction Order 10\u8211\'3f13.) Under the Court\rquote s construction of the term \u8220\'3fculturing reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms ... at a ratio of not less than 70 mole % among the entire coenzymes Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
,\u8221\'3f a manufacturer practices this limitation if, \u8220\'3fat a time prior to the extraction, oxidation, or disruption steps,\u8221\'3f one performs the assay described at column 5 between lines 8 and 43 and in Example 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, and the results show the microbial cells contain reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of not less than 70 mole % among the entire coenzymes CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The manufacturers are not required to use one of the microorganisms listed in Tables 1 through 3 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Nor are they required to perform the laboratory-scale assay described between column 4, line 51 and column 5, line 43 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. The Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\rquote  Motion to the extent it centers on these arguments.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1effcf1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1effcf1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
b. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether the Term \u8220\'3fMicroorganisms\u8221\'3f Is Limited to \u8220\'3fNon\u8211\'3fPhotosynthetic Bacteria or Yeast\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants next argue that because Kaneka explicitly disclaimed the use of photosynthetic bacteria during prosecution of the application leading to a parent of the \lquote 340 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2006416649&pubNum=0006769&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=I3a87b5d8a54111d9bdd1cfdd544ca3a4&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Patent\u8212\'3fApplication No. 10/500,249 (the \u8220\'3f\rquote 249 Application\u8221\'3f)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8212\'3fand because it is undisputed that XKGC uses the photosynthetic bacterium 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Rhodobacter sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, its processes do not practice the \u8220\'3fculturing\u8221\'3f step. (Defs.\rquote  Mem. 27.) Kaneka responds by noting that Judge Rodgers in the ITC Proceeding expressly rejected Defendants\rquote  effort to limit the \u8220\'3fmicroorganism\u8221\'3f term to nonphotosynthetic microorganisms, and also by noting that Defendants did not ask Judge Pfaelzer to so limit this term during the 2013 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 proceedings. (Defs.\rquote  Opp\rquote n 18\u8211\'3f19.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court agrees with Kaneka that the term \u8220\'3fmicroorganism ... 70 mole %\u8221\'3f is not limited to nonphotosynthetic microorganisms. Defendants did not ask for such a construction during the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 proceedings, and Judge Pfaelzer did not construe this term as requiring that nonphotosynthetic bacteria or yeast be used. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Opening Claim Construction Br., ECF No. 139, Defs.\rquote  Responsive Claim Construction Br.; Claim Construction Order 10\u8211\'3f13.) Judicial estoppel applies to patent claim construction, and Defendants are prohibited from abandoning their earlier, successfully advanced claim construction positions. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2013803663&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1341&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1341" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Biomedical Patent Mgmt. Corp. v. Cal. Dep\rquote t of Health Servs.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 505 F.3d 1328, 1341 (Fed. Cir. 2007)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018803272&pubNum=0006538&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_6538_914&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_6538_914" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Fitness Quest, Inc. v. Monti
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 330 Fed.Appx. 904, 914 (Fed. Cir. 2009)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
; 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2026283062&pubNum=0004637&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_4637_650&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_4637_650" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mondis Tech. Ltd. v. Chimei Innolux Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 822 F.Supp.2d 639, 650 n.14 (E.D. Tex. 2011)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (holding that \u8220\'3fInnoLux is judicially estopped from agreeing to a claim construction position, which this Court accepted in its claim construction order, and then urging a different position merely weeks before trial\u8221\'3f). Additionally, this argument is waived because it was not raised during the \u8220\'3fclaim construction phase\u8221\'3f of this case, nor was it raised on appeal. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2011850963&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1356&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1356" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Cent. Admixture Pharmacy Servs., Inc. v. Advanced Cardiac Sols., P.C.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 482 F.3d 1347, 1356 (Fed. Cir. 2007)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 (\u8220\'3fThe district court found that ACS waived any argument with respect to this term by failing to raise it during the claim construction phase. We agree.\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Even if the Court were inclined to consider statements made during prosecution of the \lquote 249 Application for the purpose of construing the term \u8220\'3fmicroorganism,\u8221\'3f it would not agree with Defendants that this term should be limited to \u8220\'3fnonphotosynthetic bacteria or yeast.\u8221\'3f First, Defendants\rquote  own expert, Dr. Jefferson C. Lievense, testified that \u8220\'3fbecause there is one example of a photosynthetic bacterium\u8221\'3f in the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, a person of ordinary skill in the art, when reviewing the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, would not limit the term \u8220\'3fmicroorganism\u8221\'3f to nonphotosynthetic bacteria. (Bowick Opp\rquote n Decl., Ex. 4 at 53:10\u8211\'3f15.) The specification \u8220\'3fis always highly relevant to the claim construction analysis. Usually, it is dispositive; it is the single best guide to the meaning of a disputed term.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2006931523&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1315&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1315" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Phillips v. AWH Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 415 F.3d 1303, 1315 (Fed. Cir. 2005)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1996170371&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1582&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1582" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Vitronics Corp. v. Conceptronic, Inc.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 90 F.3d 1576, 1582 (Fed. Cir. 1996)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
). Moreover, Defendants have not shown that the proposed amendment to the abandoned \lquote 249 Parent Application, attached as Exhibit C to the Mei Opening Declaration, was even considered by the examiner, and there is thus little support for importing this limitation from the prosecution history into the claims. 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2006931523&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1317&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1317" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1317
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 (\u8220\'3fYet because the prosecution history represents an ongoing negotiation between the PTO and the applicant, rather than the final product of that negotiation, it often lacks the clarity of the specification and thus is less useful for claim construction purposes.\u8221\'3f).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_23_63}{\*\bkmkend co_pp_sp_999_23_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*23
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\rquote  Motion to the extent Defendants argue their processes cannot infringe because they utilize photosynthetic bacteria.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia1f469c1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia1f469c1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
c. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether Kaneka Has Sufficient Evidence that XKGC\rquote s Process Meets the 70 Mole % Limitation
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Finally, Defendants argue summary judgment must be entered in XKGC\rquote s favor because there is no genuine dispute that XKGC\rquote s old and new manufacturing processes do not produce reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at a ratio of not less than 70 mole % at the end of the fermentation step. (Defs.\rquote  Mem. 29.) In support of this argument, Defendants contend that a person of ordinary skill in the art \u8220\'3fwould understand that the appropriate point in the process from which to take a sample for testing the ration of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 among the entire CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
s in the obtained microbial cells is the fermentation tank at or close to the end of the \lquote culturing\rquote  (i.e. fermentation) step.\u8221\'3f (Defs.\rquote  Mem. 29.) In further support of this argument, Defendants point to (1) the testimony of one of Kaneka\rquote s experts during the ITC Proceeding; and (2) Judge Rodgers\rquote  finding during the ITC Proceeding that the correct \u8220\'3fsampling point to determine whether or not the 70 mole % reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 ratio limitation is satisfied is at the end of culturing, which is the end of fermentation.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00052044683407_ID0EY1AK_63}{\*\bkmkend co_fnRef_B00052044683407_ID0EY1AK_63}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00052044683407_63" }{\fldrslt 
{\super \b0 \cf20 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
5
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 (Defs.\rquote  Mem. 29.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka responds that Judge Pfaelzer considered and rejected Defendants\rquote  argument that this determination must be made at the \u8220\'3fend of fermentation.\u8221\'3f (Defs.\rquote  Opp\rquote n 21\u8211\'3f22.) It is true that, in their opening and responsive 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 briefs, Defendants advanced this argument. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Opening Claim Construction Br., Defs.\rquote  Responsive Claim Construction Br.) Judge Pfaelzer recognized the parties\rquote  respective positions, noting that \u8220\'3f[t]he primary disagreement between the parties appears to be over the [1] timing and [2] method for determining the mole percent of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (Claim Construction Order 11.) Judge Pfaelzer disagreed with Defendants\rquote  position, and concluded that \u8220\'3f[s]ince the steps must be performed in order, and the other steps of the claim affect the mole percent of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the mole percent of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 must be determined 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
at a time prior to
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the execution of any of the subsequent steps of the claims.\u8221\'3f (Claim Construction Order 12 [emphasis added].) Both parties\rquote  experts agree that microorganisms surrounded by nutrients do not stop metabolizing simply because one \u8220\'3fstep\u8221\'3f of the manufacturing process is determined to be complete and a second \u8220\'3fstep\u8221\'3f is said to begin. What matters is whether the microorganisms continue to metabolize. Indeed, the specification of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 implicitly acknowledges this reality, stating \u8220\'3fit is preferable to supply the ... carbon sources to the culture medium separately from other components.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Patent col. 8, ll. 51\u8211\'3f53.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court first considers whether a genuine dispute exists as to whether XKGC\rquote s old manufacturing process practiced the 70 mole % limitation. Kaneka has introduced evidence that two sets of samples collected in February and March of 2012 by Alliance Technologies\u8212\'3fboth of which were \u8220\'3fflash frozen in liquid nitrogen\u8221\'3f and the latter of which were stored on dry ice\u8212\'3fdemonstrated that XKGC\rquote s old plant cultured reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
-producing microorganisms such that more than 70 mole % of the entire CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
s were reduced after assaying. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Bowick Opp\rquote n Decl., Ex. 30 at 15, 18, 20, 28 [showing results of \u8220\'3f82.1\u8211\'3f87.9 mole %\u8221\'3f and between 73.5 and 74.7 mole %]; Ex. 12 at 125:14\u8211\'3f16, 126:11\u8211\'3f128:10, 141:15\u8211\'3f142:13, 145:5\u8211\'3f11, 146:12\u8211\'3f16, 152:14\u8211\'3f153:13.) Again, because Judge Pfaelzer\rquote s construction of the 70 mole % term does not require that testing be performed at the \u8220\'3fend of fermentation,\u8221\'3f these samples, which were taken hours before the \u8220\'3fend of fermentation,\u8221\'3f are seemingly sufficient to create a genuine dispute regarding whether XKGC\rquote s old process practiced the 70 mole % limitation. Moreover, disputes regarding the method of storage between collection and sampling must be resolved by the trier of fact, as the Court in ruling on summary judgment motions must make all reasonable inferences in the light most favorable to Kaneka, the nonmovant. The Court therefore concludes that a genuine issue of fact exists regarding whether XKGC\rquote s old manufacturing process practiced the 70 mole % limitation, and 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\u8217\'3f Motion for Summary Judgment on this ground.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_24_63}{\*\bkmkend co_pp_sp_999_24_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*24
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The Court reaches a different conclusion, however, with respect to XKGC\rquote s new manufacturing process. The only pieces of evidence Kaneka cites in support of its contention that XKGC\rquote s new process practices the 70 mole % limitation are the results of two tests conducted by PharmaForensics Labs on July 18, 2016 and July 20, 2016, respectively, that apparently resulted in ratios of reduced CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 of 79.6% and 78.9%, respectively. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Bowick Opp\rquote n Decl., Ex. 1 \u182\'3f 16; Ex. 28 at KAN\u8211\'3fCD\u8211\'3fCAL 23689, 23692.) In its February 22, 2017 Order, the Court reviewed the methods used to conduct these tests and Dr. Sherman\rquote s opinions and testimony regarding these tests, and found the test results and Dr. Sherman\rquote s associated testimony to be inadmissible under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000607&cite=USFRER702&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rule 702 of the Federal Rules of Evidence
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_590&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_590" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 509 U.S. at 590, 113 S.Ct. 2786
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Following this ruling, the Court asked the parties to file supplemental briefing regarding the impact of the Court\rquote s February 22, 2017 Order on Defendants\u8217\'3f motion for summary judgment on non-infringement with respect to the \u8220\'3f70 mole %\u8221\'3f limitation. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(Minute Order, ECF No. 766.) Kaneka\rquote s supplemental brief did not address this question, but instead noted the tentative nature of motions in limine and argued for the Court to reconsider its ruling. (P\rquote s Supplemental Brief, ECF No. 770\u8211\'3f1.) In support of its request, Kaneka provided three peer-reviewed articles discussing organic solvent toxicity and a new study, conducted by Kaneka, purporting to examine the toxicity of n-hexane on 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Rhodobacter sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (\u8220\'3f
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
R. Sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f). (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally,
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Declaration of David Sherman, PhD ISO Kaneka\rquote s Suppl. Brief in Opposition to Defendants\u8217\'3f Motion for Summary Judgment (\u8220\'3fSherman Decl. ISO Suppl. Brief\u8221\'3f) Exhs. A\u8211\'3fE, ECF No. 770\u8211\'3f2\u8211\'3f6.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The journal articles proffered by Kaneka are largely unhelpful because none discuss, or even mention, the relevant bacterium\u8212\'3f
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Rhodobacter sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Kaneka asks the Court to conclude from this that 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
R. sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 has not been identified as an organic-solvent-resistant bacteria, noting that \u8220\'3fnothing in the scientific literature suggests that 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Rodobacter spheroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 can resist n-hexane in small amounts, let along the very large amounts used by Dr. Sherman.\u8221\'3f (P\rquote s Suppl. Brief, fn. 4.) Nowhere, however, do these articles claim to present an exhaustive list of all such \u8220\'3fextremophile\u8221\'3f bacteria; on the contrary, they openly acknowledge that \u8220\'3ffresh habitats need to be explored to isolate other species displaying such tolerance.\u8221\'3f (Sherman Decl. ISO Suppl. Brief, Exh. A at 267.) More importantly, while the articles identify the partition coefficient (\u8220\'3fLog P
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
ow
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8221\'3f) as a useful measure of solvent toxicity, none address the rate at which bacteria are disabled once they are exposed to toxic solvents and therefore do not establish that exposure to a mixture of n-hexane and isopropanol \u8220\'3fimmediately kills the microorganisms upon contact\u8221\'3f such that refrigeration would be \u8220\'3funnecessary.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Cf.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Decl. Robert M. Bowick in Opp\rquote n Defs.\u8217\'3f Mot. For Summ. J., Ex. 2 (\u8220\'3fSherman Infringement Report\u8221\'3f) \u182\'3f 122, ECF No. 605\u8211\'3f5.) In essence, Kaneka\rquote s articles only establish that: (1) some bacteria are resistant to organic solvents, (2) some bacteria are not resistant to organic solvents, and (3) organic solvents vary in their degree of toxicity. None of this information serves to validate Dr. Sherman\rquote s decision to deviate from his own protocol.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Presumably seeking to rectify the lack of information specific to 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
R. sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Kaneka also offers a new study\u8212\'3fperformed August 29\u8211\'3fSeptember 5, 2017\u8212\'3fthe stated purpose of which is to \u8220\'3f[a]ssess the ability of 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
R.sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 culture to maintain viability following exposure to organic solvents.\u8221\'3f (Sherman Decl. ISO Suppl. Brief, Exh. E at 2.) The study introduced a mixture of n\u8211\'3fhexane and 2\u8211\'3fpropanol to a sample of 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
R. sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 and, after a set period of time, assayed the bacteria-solvent mixture, placed it on an agar plate and incubated it for three days. At the end of the three-day period, none of the bacteria were living, even those only directly exposed to the organic solvent for fifteen (15) seconds. (Sherman Decl. ISO Suppl. Brief, Exh. E at 4\u8211\'3f5.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka\rquote s study is defective both because the experimental design is flawed and because it does not purport to test the relevant question. The experiment involves withdrawing the bacteria-solvent mixture after a set period of time and depositing this mixture onto an agar plate. Simply withdrawing the assay from the larger mixture does not remove the bacteria from the solvent because the assay itself contains both. The solvent remains in contact with the bacteria until it evaporates from the plate\u8212\'3fa time period not measured by the experiment. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Thus, the bacteria was not only exposed to organic solvent for 15 seconds, it was also exposed to organic solvent for the time necessary to transfer the assay to the agar gel and the time required for the solvent to fully evaporate. This problem is further exacerbated by the fact that the agar plates are chilled to 4 degrees centigrade, slowing the evaporation rate. (Sherman Decl. ISO Suppl. Brief, Exh. E at 3.) The procedure also fails to address whether the agar plates are sealed or left open when placed into the incubator. If the plates are sealed\u8212\'3fas is customary\u8212\'3fthe bacteria could have been exposed to organic solvent vapor for all three days of incubation. The experiment\rquote s second flaw is its failure to directly test the relevant question: whether exposure to the mixture of n-hexane and isopropanol \u8220\'3fimmediately\u8221\'3f kills 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
R. sphaeroides
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 such that the deviation from Dr. Sherman\rquote s proposed testing procedure is immaterial. While it does seek to test the lifespan of these microorganisms, it does not meaningfully compare this process to the PharmaForensics protocol.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_25_63}{\*\bkmkend co_pp_sp_999_25_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*25
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 As Plaintiff has failed to cure the defect identified in Dr. Sherman\rquote s report in the original 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s request to reconsider that finding. Kaneka and its witnesses are precluded from testifying and offering opinions regarding the results of their testing of the 70 mole % limitation under Dr. Sherman\rquote s July 2016 protocol. Accordingly, because Kaneka has introduced no admissible evidence showing there is a genuine dispute as to whether XKGC\rquote s new manufacturing process practices the 70 mole % limitation, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\u8217\'3f Motion for Summary Judgment that XKGC\rquote s new manufacturing process does not infringe the asserted claims.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia2018921053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia2018921053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether Defendants Use a \u8220\'3fSealed Tank\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants next challenge whether Manufacturing Defendants\rquote  processes use a \u8220\'3fsealed tank,\u8221\'3f arguing that Kaneka \u8220\'3fessentially conceded\u8221\'3f in its 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and earlier summary judgment papers that it would be impossible to have a \u8220\'3fsealed tank\u8221\'3f in an industrial-scale process as the term has been construed by the Federal Circuit. (Defs.\rquote  Mem. 31\u8211\'3f32.) Defendants note that although Kaneka sought to construe the term \u8220\'3fsealed tank\u8221\'3f to mean \u8220\'3fa tank that 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
substantially
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 prevents direct exposure of its contents to the atmosphere,\u8221\'3f the Federal Circuit rejected this proposed construction, instead construing the term as \u8220\'3fa tank that prevents exposure of the tank\rquote s contents to the atmosphere.\u8221\'3f (Defs.\rquote  Mem. 32.) Defendants do not cite any evidence in support of this argument, and do not reference the \u8220\'3frelief valve\u8221\'3f discussed at length in their initial motion for summary judgment filed after the Federal Circuit issued its mandate. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Cf.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Mot. for Summ. J. as to Invalidity and Noninfringement, ECF No. 355.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka responds that Dr. Spormann failed to apply the Federal Circuit\rquote s construction in providing his non-infringement opinions, creating his own interpretation of \u8220\'3fsealed tank\u8221\'3f by adding the qualifier \u8220\'3fall the time.\u8221\'3f (Bowick Opp\rquote n Decl., Ex. 12 at 161:21\u8211\'3f162:22, 214:11\u8211\'3f215:1.) Kaneka next points out that Shenzhou employees testified that Shenzhou\rquote s old and new extraction processes, which are described in Standard Operating Procedures (\u8220\'3fSOPs\u8221\'3f), are performed in tanks that are sealed. (Defs.\rquote  Opp\rquote n 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf1 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.) Kaneka submits that this evidence, coupled with the opinions and testimony of its expert, is sufficient to defeat summary judgment.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia20336d1053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia20336d1053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
a. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
The Court\rquote s Construction of \u8220\'3fSealed Tank\u8221\'3f and Plaintiff\rquote s Motion for Reconsideration
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In the Judge Pfaelzer\rquote s original claim construction order, the term \u8220\'3fsealed tank\u8221\'3f was construed to mean \u8220\'3fa tank that is closed to prevent the entry or exit of 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
materials
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (emphasis added) (Claim Construction Order, 9.) On appeal, the Federal Circuit reversed this construction, finding that it improperly excluded one of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8217\'3fs preferred embodiments. (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036432113&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1304&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1304" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Kaneka Corp. v. Xiamen Kingdomway Group Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 790 F.3d 1298, 1304 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Instead, the Circuit determined that a \u8220\'3f \lquote sealed tank\rquote  should be sealed to the atmosphere, but not necessarily to other materials, such as solvents\u8221\'3f and, based on this understanding, held that \u8220\'3fthe term \lquote sealed tank,\u8221\'3f means \lquote a tank that prevents exposure of the tank\rquote s contents to the atmosphere.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036432113&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1304&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1304" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 1304\u8211\'3f5
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In its February 22, 2017 Order addressing arguments raised in the parties\u8217\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 motions, the Court referred to a portion of the Federal Circuit\rquote s ruling which held:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_26_63}{\*\bkmkend co_pp_sp_999_26_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*26
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In the industrial scale process of Example 8, a solution of disrupted (ruptured) cells containing reduced coenzyme Q10 is \u8220\'3fsealed with nitrogen gas,\u8221\'3f i.e., sealed under an inert gas atmosphere 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
such that solution contents are not exposed to the atmosphere, and continuously extracted
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 in a manner that allows solvent to flow into and out of the extraction tanks depicted in Figure 1.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order, 11.) From this, the Court concluded that \u8220\'3f[t]he only tenable reading of this limitation is that the tank must prevent exposure of its contents to the atmosphere for the entire duration of the extraction step, or else the contents of the tank could be exposed to the atmosphere for at least a portion of the extraction step.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order, 11.) Plaintiff now challenges this conclusion as improperly adding an additional limitation to the Federal Circuit\rquote s existing construction of \u8220\'3fsealed tank.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Motion for Reconsideration, ECF No. 819\u8211\'3f1.) Kaneka asserts that the additional language \u8220\'3fnecessarily exclude[s] the preferred embodiment of Example 8 and Figure 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8216\'3f340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f (Declaration of David Sherman PhD ISO Mot. for Reconsideration \u182\'3f 14, ECF No. 819\u8211\'3f2.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The basis for Kaneka\rquote s claim is that the industrial tanks used for extraction must, at some point, be filled with solvent, displacing any air contained within the extraction tank. (Sherman Decl. ISO Reconsideration \u182\'3f 13.) If this air is not bled off during the filling process, the tank would become pressurized with compressed air and solvent vapor\u8212\'3fan unworkable and highly dangerous proposition. (Sherman Decl. ISO Reconsideration \u182\'3f 11.) The alternative solution of placing the tank under complete vacuum during the filling process is a similarly impractical, if not impossible, requirement. (Sherman Decl. ISO Reconsideration \u182\'3f 7.) Plaintiff is therefore correct that requiring a hermetically-sealed tank during the extraction process is inconsistent with the patent specification as read by a person of ordinary skill in the art. The Court\rquote s February 22, 2017 Order, however, makes no such demand. While it does conclude that the tank must be sealed during the entirety of the extraction process, it requires only that the contents of the tank not be exposed to the atmosphere\u8212\'3fnot that the atmosphere be protected from the contents of the tank. (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1993130674&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Daubert
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Order, 11.) Thus, the use of a seal pot or some other one-way check valve that allows gas to escape the container while the tank is being filled, but does not allow atmospheric oxygen to enter, is sufficient to render a tank \u8220\'3fsealed\u8221\'3f for purposes of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. This understanding is fully consistent with the patent specification which discloses that, at least with respect to reduced coenzyme Q
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the primary concern during the extraction step is preventing oxidation. (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Patent col. 16:16\u8211\'3f54.) Exposing the tank\rquote s contents to the atmosphere at any point during the extraction process would introduce additional oxygen into the tank and thereby frustrate this goal. Because the Court\rquote s construction permits venting of air during the filling process, it does not conflict with Example 8 or Figure 1 of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8216\'3f340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court further notes that the case law relied upon by Plaintiff in its Motion for Reconsideration is inapposite. Kaneka cites a related case appealed from the Southern District of Texas in which the Federal Circuit rejected the lower court\rquote s construction of the term \u8220\'3foxidation.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040812168&pubNum=0006538&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_6538_964&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_6538_964" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Zhejiang Medicine Co., Ltd. v. Kaneka Corp
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
., 676 Fed. Appx. 962, 964 (Fed. Cir. 2017)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Contrary to Kaneka\rquote s assertion, however, the rejection was not because the district court further clarified the Circuit\rquote s previous construction, but rather because the lower court\rquote s construction lacked precision. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2040812168&pubNum=0006538&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In point of fact, by arguing that a \u8220\'3fsealed tank\u8221\'3f may sometimes be open and sometimes be closed, Kaneka seeks to introduce exactly the type of ambiguity and imprecision that the Federal Circuit sought to avoid. If a tank that is open for 5% of the extraction process is \u8220\'3fsealed,\u8221\'3f it begs the question whether the same logic applies to a tank that is open 25% of the time, or 95% of the time. Moreover, Plaintiff has already litigated this issue before the Federal Circuit in its initial appeal when it sought to construe \u8220\'3fsealed tank\u8221\'3f as \u8220\'3fa tank that 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
substantially
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 prevents direct exposure of its contents to the atmosphere.\u8221\'3f (Brief for Plaintiff\u8211\'3fAppellant (\u8220\'3fKaneka App. Brief\u8221\'3f) at 49, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036432113&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Kaneka Corp. v. Xiamen Kingdomway Group Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 790 F.3d 1298 (Fed. Cir. 2015)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.) While the Circuit accepted some of Kaneka\rquote s proposed construction, it conspicuously chose not to include \u8220\'3fsubstantially\u8221\'3f or any similarly equivocal language. This Court follows the Federal Circuit\rquote s lead and declines to add such a limitation at this time.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_27_63}{\*\bkmkend co_pp_sp_999_27_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*27
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Plaintiff\rquote s reliance on 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995115215&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Bell Commc\rquote ns Research, Inc. v. Vitalink Commc\rquote ns Corp.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is similarly misplaced. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995115215&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
55 F.3d 615 (Fed. Cir. 1995)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. There, the Federal Circuit considered an asserted claim requiring a data packet to travel along a single, assigned network tree. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995115215&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_622&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_622" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 622
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Because the accused system consisted of packets capable of switching, mid-course, from one tree to another, the district court concluded that there was no literal infringement. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995115215&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The appellate court observed that \u8220\'3fthe record does not make it clear that [defendant]\u8217\'3fs system 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
never
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 uses the claimed method,\u8221\'3f thereby implying that there may be situations in which the packet does not, in fact, switch network trees and therefore may literally infringe at least some of the time. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995115215&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Without making an ultimate determination on the issue of infringement, the case was remanded with instructions that \u8220\'3fan accused product that sometimes, but not always, embodies a claimed method nonetheless infringes.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995115215&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka contends that this holding requires the Court to consider a tank that, for some period of time, exposes its contents to the atmosphere to nevertheless be a \u8220\'3fsealed tank.\u8221\'3f (Mot. For Reconsideration, 8.) This argument, however, appears to be based on a misunderstanding of the biphasic nature of infringement analysis. Before a court considers a defendant\rquote s accused product, it must first determine the proper scope of the asserted claim terms as presented in the patent and understood by a person of ordinary skill in the art. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_976&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_976" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Markman
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 52 F.3d at 976
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. It is only once the claim scope is understood that a court may determine if a defendant infringes those claims. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1995081690&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s argument goes to the first of these steps\u8212\'3fclaim interpretation\u8212\'3fwhile the court in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Bell Commc\rquote ns
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 addressed the second. Had Kaneka shown, for example, that Defendants sometimes perform their process with an open tank and sometimes with a sealed tank, the principle from 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Bell Commc\rquote ns
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 would apply. Here, however, Plaintiff does not allege that Defendants\u8217\'3f process differs from run to run, but rather asks the Court to alter its construction of \u8220\'3fsealed tank.\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
For these reasons, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Kaneka\rquote s Motion for Reconsideration and continues to interpret the term \u8220\'3fsealed tank\u8221\'3f as requiring the tank to prevent exposure of its contents to the atmosphere for the entire duration of the extraction step.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia20b9b41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia20b9b41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
b. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether a Genuine Dispute Exists as to Manufacturing Defendants\rquote  Literal Usage of \u8220\'3fSealed Tanks\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Even with this understanding, the Court finds that a genuine dispute exists as to whether the old and new processes used by XKGC literally perform extraction using \u8220\'3fsealed tanks,\u8221\'3f and accordingly 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 summary judgment in favor of Defendants on this issue. Kaneka\rquote s expert, Dr. Sherman, testified and opined that XKGC\rquote s new and old processes extract CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 in a \u8220\'3fsealed tank\u8221\'3f because although these processes include relief valves that can expose the tank\rquote s contests to the atmosphere, XKGC\rquote s SOP, coupled with the purpose of the relief valve\u8212\'3fto prevent the build up of the solvent hexane, which can create an explosion if too pressurized\u8212\'3freveal that the valves \u8220\'3fclose to prevent any potential drawing in of atmospheric air exposed to the hexane ...\u8221\'3f (Bowick Opp\rquote n Decl., Ex. 36 at 318:15\u8211\'3f321:20; Ex. 2 at 161\u8211\'3f190; Exs. 37\u8211\'3f38; Ex. 41 at 586:4\u8211\'3f22; Exs. 46\u8211\'3f47.) Kaneka also points to its Final Infringement Contentions, which detail why XKGC\rquote s new and old processes use \u8220\'3fsealed tanks\u8221\'3f relying on their SOP and certain deposition testimony. (Kaneka\rquote s FICs for XKGC at 26\u8211\'3f31.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants do not directly challenge Dr. Sherman\rquote s testimony or opinions, nor do they offer any affirmative evidence of their own. Instead, they rely on a submission by Kaneka in a 2013 brief opposing summary judgment that a \u8220\'3fsealed tank\u8221\'3f in an industrial-scale process can only be \u8220\'3fsubstantially\u8221\'3f sealed \u8220\'3fbecause the absolute nature of complete oxygen exclusion and/or absolute retention of all organic solvent presents certain logistical and system-based difficulties that operate contrary to known realities inherent to any industrial scale production process.\u8221\'3f (Defs.\rquote  Mem. 32; Defs.\rquote  Reply 18, ECF No. 611\u8211\'3f1.) As a preliminary matter, the Ninth Circuit holds that \u8220\'3fstatements of fact contained in a brief may be considered admissions of the party in the discretion of the district court.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1988143992&pubNum=0000350&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_350_227&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_350_227" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Am. Title Ins. Co. v. Lacelaw Corp.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 861 F.2d 224, 227 (9th Cir. 1988)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Given this statement was made in the context of Kaneka opposing summary judgment under a since-reversed claim construction ruling, the Court does not find the statement to be tantamount to a judicial admission that the extraction tanks are not \u8220\'3fsealed,\u8221\'3f as the term has since been construed by the Federal Circuit. Even if the Court were to treat this submission as a binding admission, however, it would not conclude that Kaneka has admitted Defendants\rquote  processes do not extract in \u8220\'3fa tank that prevents exposure of the tank\rquote s contents to the atmosphere.\u8221\'3f This opinion is limited to large industrial tanks subjected to the continuous exchange of liquids and gases. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Mem. Ps. & As. in Opp\rquote n to Mot. for Summ. J. on the Issue of Non-Infringement 21, ECF No. 218.) On the present record, the Court cannot say whether Shenzhou or XKGC\rquote s old or new processes use industrial extraction tanks subjected to the continuous exchange of liquids and gases.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia20e0c41053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia20e0c41053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
b. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether a Genuine Dispute Exists as to Manufacturing Defendants\rquote  Usage of \u8220\'3fSealed Tanks\u8221\'3f under the DOE
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_28_63}{\*\bkmkend co_pp_sp_999_28_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*28
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendants next argue that Manufacturing Defendants\rquote  processes do not meet the \u8220\'3fsealed tank\u8221\'3f limitation under the DOE, both because Dr. Sherman did not address any alleged infringement under this doctrine and because Kaneka is barred from asserting infringement of this claim limitation under the doctrine of prosecution history estoppel. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defs.\rquote  Mem. 33.)
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
As a threshold matter, the Court granted Kaneka leave to amend its Final Infringement Contentions to include infringement of the \u8220\'3fsealed tank\u8221\'3f limitation under the DOE. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Order Granting in Part & Den. in Part Pl.\rquote s Mot. for Leave to Amend Its FICs, ECF No. 513.) The Court therefore rejects Defendants\rquote  challenge on this ground.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The Court next addresses whether Kaneka is barred from asserting infringement under the DOE because of prosecution history estoppel. \u8220\'3fEstoppel arises when an amendment is made to secure the patent and the amendment narrows the patent\rquote s scope.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_736&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_736" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo VIII
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 535 U.S. at 736, 122 S.Ct. 1831
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fA patentee who narrows a claim as a condition for obtaining a patent disavows his claim to the broader subject matter, whether the amendment was made to avoid the prior art or to comply with 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_737&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_737" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 737, 122 S.Ct. 1831
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. In 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Festo
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, the United States Supreme Court provided an overview of the doctrine:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
The doctrine of equivalents allows the patentee to claim those insubstantial alterations that were not captured in drafting the original patent claim but which could be created through trivial changes. When, however, the patentee originally claimed the subject matter alleged to infringe but then narrowed the claim in response to a rejection, he may not argue that the surrendered territory comprised unforeseen subject matter that should be deemed equivalent to the literal claims of the issued patent. On the contrary, \u8220\'3f[b]y the amendment [the patentee] recognized and emphasized the difference between the two phrases[,] ... and [t]he difference which [the patentee] thus disclaimed must be regarded as material.\u8221\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_733&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_733" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 733\u8211\'3f34
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. \u8220\'3fEstoppel is a \lquote rule of patent construction\rquote  that ensures that claims are interpreted by reference to those \lquote that have been cancelled or rejected.\rquote  \u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2002330186&pubNum=0000780&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_780_733&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_733" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 at 733, 122 S.Ct. 1831
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=1940126226&pubNum=0000708&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_708_220&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_220" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Schriber\u8211\'3fSchroth Co. v. Cleveland Trust Co.
}
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 311 U.S. 211, 220\u8211\'3f21, 312 U.S. 654, 61 S.Ct. 235, 85 L.Ed. 132 (1940)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
).
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Defendants argue that, during prosecution of the application leading to the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2024833970&pubNum=0004074&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=PA&docFamilyGuid=Idb1056d254c011e085acc3f6d5ffa172&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\rquote 340 Patent
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 (Appl. No. 11/981,181), after repeated rejections of its claims by the PTO, Kaneka submitted an Amendment canceling old claims and adding new ones. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\u8217\'3f Mem. 33.) Among these new claims were claims 131 and 142, which the patentee claimed were not obvious in light of certain prior art references because these references \u8220\'3ffail[ ] to provide any teaching or suggestion\u8221\'3f of extraction by an organic solvent \u8220\'3fin a sealed tank.\u8221\'3f (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Mei Opening Decl., Ex. K at MGC00122101\u8211\'3fMGC00122107.) These claims ultimately issued as claims 22 and 33.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kaneka does not cite to, much less grapple with, the doctrine of prosecution history estoppel once in its papers. (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Opp\rquote n.) Instead, Kaneka cites to cases discussing the role of the jury in determining infringement under the DOE and the type of evidence sufficient to establish such infringement. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
(
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Opp\rquote n 38.) Moreover, the main authority cited by Kaneka regarding the DOE, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2011551577&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \i1 \fs20 
{\b0 \cf20 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
AquaTex Industries v. Techniche Solutions
}
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, shows why Kaneka has failed to carry its summary judgment burden with respect to the issue of prosecution history estoppel:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_29_63}{\*\bkmkend co_pp_sp_999_29_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*29
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Under th[e] doctrine [of prosecution history estoppel], the surrender of subject matter during patent prosecution creates a presumption that the patentee is precluded from recapturing that subject matter through the doctrine of equivalents; this presumption can be rebutted by the patentee through a 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
showing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 that an amendment was unrelated to patentability.
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2011551577&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1325&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1325" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
479 F.3d 1320, 1325 (Fed. Cir. 2007)
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
. Kaneka has failed to introduce any evidence or argument as to why the addition of the term \u8220\'3fin a sealed tank\u8221\'3f during prosecution was unrelated to patentability, particularly in light of the patentee\rquote s statements contained in the Amendment distinguishing certain prior art references. As such, the Court 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 summary judgment in favor of Defendants that XKGC\rquote s manufacturing processes do not practice the \u8220\'3fsealed tank\u8221\'3f limitation under the doctrine of equivalents.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia2133c61053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia2133c61053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
3. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa200 \sb400 
Whether Defendants\rquote  Processes Contain an \u8220\'3fActive Oxidation\u8221\'3f Step
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
Finally, Defendants argue that they do not infringe claim 22 because Manufacturing Defendants\rquote  processes do not perform the \u8220\'3foxidizing\u8221\'3f step. (Defs.\rquote  Mem. 34.) In particular, they contend that because Kaneka has not presented \u8220\'3fa baseline rate of passive oxidation to show that the alleged pre-extraction \lquote oxidizing step\rquote  (i.e., washing and drying steps) is active oxidation in [ ] XKGC\rquote s process,\u8221\'3f summary judgment of noninfringement must be entered in their favor. (Defs.\u8217\'3f Mem. 34.) Kaneka does not dispute that it does not have a \u8220\'3fbaseline rate of passive oxidation,\u8221\'3f but argues it nevertheless has sufficient evidence to withstand summary judgment on this issue.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Since the filing of the parties\rquote  cross-motions for summary judgment, the Court of Appeals for the Federal Circuit has issued an opinion regarding an appeal from the Texas Litigation (the \u8220\'3f
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
ZMC
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Opinion\u8221\'3f). (
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defs.\rquote  Second Notice of Supplemental Authority and Partial Withdrawal of Summ. J. Mot. (\u8220\'3fNotice\u8221\'3f), Ex. A, ECF No. 636.) In the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
ZMC
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Opinion, the Federal Circuit held, among other things, that the construction of the oxidizing steps does not require increased oxidation in excess of that which occurs naturally from exposure to ambient air. (Notice, Ex. A at 6.) In light of the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
ZMC
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Opinion, Defendants \u8220\'3fwithdraw the part of their Motion for Summary Judgment that is based on Kaneka\rquote s failure to present a baseline rate for passive oxidation to prove infringement of claim 22.\u8221\'3f (
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&pubNum=0004502&cite=NOTICE1&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Notice 1
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
.)
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia214c301053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia214c301053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_Ia214c301053411eb905aadf6789ca}{\*\bkmkend co_anchor_Ia214c301053411eb905aadf6789ca}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
IV. 
}
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul1 \strike0 \i0 \fs20 \sa0 \sb400 
RULING
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
For the foregoing reasons, the Court:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
1. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 both Kaneka\rquote s and Defendants\u8217\'3f Motions for Summary Judgment on the issue of whether the asserted claims are indefinite under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS112&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 112
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 \u182\'3f 2;
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
2. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Motion for Summary Judgment that the asserted claims are patent-eligible under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u167\'3f
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
101
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
;
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
3. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Motion for Summary Judgment that 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Folkers
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 does not anticipate any of the asserted claims under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. Section 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
;
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
4. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Kaneka\rquote s Motion for Summary Judgment that Kaneka\rquote s 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Pre\u8211\'3f2002 Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 do not anticipate the asserted claims under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS102&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf22 \f2 \i0 \fs20 \chcbpat23 
{\b1 \cf22 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
35
}
}
{\b0 \cf20 \f2 \i0 \fs20 \chcbpat2 
}
{\b0 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 U.S.C. \u167\'3f 102
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
;
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
5. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendants\u8217\'3f Motion for Summary Judgment to the extent they seek summary adjudication that XKGC\rquote s old manufacturing does not practice one or more aspects of the \u8220\'3fculturing\u8221\'3f step recited in the asserted claim, but 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\u8217\'3f Summary Judgment that XKGC\rquote s new manufacturing process does not practice the 70 mole % limitation;
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
6. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendants\u8217\'3f Motion for Summary Judgment that XKGC\rquote s Defendants\rquote  processes do not literally extract CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 in a \u8220\'3fsealed tank,\u8221\'3f but 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GRANTS
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Defendants\u8217\'3f Motion for Summary Judgment that XKGC\rquote s processes do not extract CoQ
}
{\b0 \cf1 \f2 \i0 \fs16 
{\sub \b0 \cf1 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 in a \u8220\'3fsealed tank\u8221\'3f under the doctrine of equivalents; and
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_30_63}{\*\bkmkend co_pp_sp_999_30_63}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*30
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 7. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
DENIES
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
 Defendants\u8217\'3f Motion for Summary Judgment that XKGC does not practice the \u8220\'3foxidizing\u8221\'3f limitation of claim 22.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
The Court is in receipt of Kaneka\rquote s Notice of Proposed Stipulation of Non-infringement based on the Court\rquote s Rulings (ECF No. 831) and Defendants\u8217\'3f Response (ECF No. 833). Now that a decision has been rendered, the parties shall advise the Court how they wish to proceed.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
IT IS SO ORDERED.
\par 
}
}
}
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf21 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_allCitations_63}{\*\bkmkend co_allCitations_63}
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
All Citations
\par 
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Not Reported in Fed. Supp., 2018 WL 2718036
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \ltrrow \trleft0 
\clpadl200 \clpadfl3 \clbrdrt \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf1 \f4 \i0 \fs20 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Footnotes
\par 
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \ql \li0 \fs20 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00012044683407_63}{\*\bkmkend co_footnote_B00012044683407_63}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00012044683407_ID0EVOAC_63" }{\fldrslt 
{\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
1
}\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Of the Original Defendants, only XKGC and PRI remain as defendants in the instant action. (
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Order Re: Transfer, ECF No. 39; Order Severing and Transferring Claims, ECF No. 47; Stipulated Settlement and Dismissal Order Between Kaneka and MGC, ECF No. 154; Order of Dismissal Between Kaneka and Maypro, ECF No. 287; Stipulated Settlement and Dismissal Between Kaneka and Shenzhou, ECF No. 784; Stipulated Settlement and Dismissal of Sojitz and Rochem, ECF No. 787.)
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00022044683407_63}{\*\bkmkend co_footnote_B00022044683407_63}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00022044683407_ID0E3EAI_63" }{\fldrslt 
{\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
2
}\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The parties do not dispute that the experts who testified during the ITC proceeding are persons of ordinary skill in the art.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00032044683407_63}{\*\bkmkend co_footnote_B00032044683407_63}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00032044683407_ID0E2KCI_63" }{\fldrslt 
{\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
3
}\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
These steps include (1) \u8220\'3fperforming 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=mproc&entityId=Iba875d73475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
density gradient fractionation
}\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 on a set of previously frozen and thawed cells to separate out the viable ones;\u8221\'3f (2) \u8220\'3frecovering the separated viable cells;\u8221\'3f and (3) \u8220\'3fcryopreserving the recovered cells.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1047&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1047" }{\fldrslt 
{\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
827 F.3d at 1047
}\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. A dependent claim required \u8220\'3fthe additional step of pooling hepatocytes from multiple donors,\u8221\'3f which was unconventional. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2039315377&pubNum=0000506&originatingDoc=I59a0a1f06a1f11e8abc79f7928cdeab9&refType=RP&fi=co_pp_sp_506_1049&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1049" }{\fldrslt 
{\b0 \cf20 \f4 \i1 \fs18 
{\b0 \cf20 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 1049
}\b0 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00042044683407_63}{\*\bkmkend co_footnote_B00042044683407_63}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00042044683407_ID0EDBAK_63" }{\fldrslt 
{\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
4
}\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Kaneka argues in its reply that Dr. Spormann \u8220\'3fcannot raise an issue of fact simply by submitting an expert declaration contradicting his sworn testimony.\u8221\'3f (Kaneka Reply 3, ECF No. 610.) The Court, however, reaches its conclusion without relying on Dr. Spormann\rquote s declaration.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrb \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00052044683407_63}{\*\bkmkend co_footnote_B00052044683407_63}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00052044683407_ID0EY1AK_63" }{\fldrslt 
{\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
5
}\super \b0 \cf20 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Court recognizes the dispositive nature of this construction in light of the exclusion of Dr. Sherman\rquote s test results. Despite the persuasive logic of Judge Rodger\rquote s conclusion, however, the Court ultimately declines to disturb Judge Pfaelzer\rquote s carefully considered ruling.
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \lastrow \trleft0 
\clpadt24 \clpadft3 \clpadl100 \clpadfl3 \clpadr24 \clpadfr3 \clbrdrt \brdrcf24 \brdrw10 \brdrs \clbrdrb \clbrdrl \trql \clvertalt \clwWidth4320 \cellx4320 
\clpadt29 \clpadft3 \clpadl100 \clpadfl3 \clpadr29 \clpadfr3 \clbrdrt \brdrcf24 \brdrw10 \brdrs \clbrdrb \clbrdrr \trql \clvertalt \clwWidth5760 \cellx10080 
\intbl 
{\ri24 \li24 
{\b1 \cf24 \f4 \ri24 \i0 \ql \fs16 \li24 
{\b1 \cf24 \f4 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
End of Document
\par 
}
}
}\b1 \cf24 \f4 \ri24 \ul0 \strike0 \i0 \ql \li24 \fs16 \sa0 \sb0 \intbl \cell \intbl 
{\ri29 \li29 
{\qr \b0 \cf24 \f4 \ri29 \i0 \fs19 \li29 
{\b0 \cf24 \f4 \ul0 \strike0 \i0 \fs19 \sa0 \sb0 
\u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
\par 
}
}
}\qr \b0 \cf24 \f4 \ri29 \ul0 \strike0 \i0 \li29 \fs19 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}\sect }